<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en">
    
    <head><meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
        <!-- AppResources meta begin -->
        <meta name="paf-app-resources" content="" />
                 <script type="text/javascript">var ncbi_startTime = new Date();</script>
            
        <!-- AppResources meta end -->
        
        <!-- TemplateResources meta begin -->
        <meta name="paf_template" content="" />

        <!-- TemplateResources meta end -->
        
        <!-- Logger begin -->
        <meta name="ncbi_db" content="books" /><meta name="ncbi_pdid" content="book-part" /><meta name="ncbi_acc" content="NBK1280" /><meta name="ncbi_domain" content="gene" /><meta name="ncbi_report" content="record" /><meta name="ncbi_type" content="fulltext" /><meta name="ncbi_objectid" content="" /><meta name="ncbi_pcid" content="/NBK1280/" /><meta name="ncbi_pagename" content="Pachyonychia Congenita - GeneReviews® - NCBI Bookshelf" /><meta name="ncbi_bookparttype" content="chapter" /><meta name="ncbi_app" content="bookshelf" />
        <!-- Logger end -->
        
        <title>Pachyonychia Congenita - GeneReviews® - NCBI Bookshelf</title>
        
        <!-- AppResources external_resources begin -->
        <link rel="stylesheet" href="/core/jig/1.14.8/css/jig.min.css" /><script type="text/javascript" src="/core/jig/1.14.8/js/jig.min.js"></script>

        <!-- AppResources external_resources end -->
        
        <!-- Page meta begin -->
        <meta name="robots" content="INDEX,FOLLOW,NOARCHIVE" /><meta name="citation_inbook_title" content="GeneReviews® [Internet]" /><meta name="citation_title" content="Pachyonychia Congenita" /><meta name="citation_publisher" content="University of Washington, Seattle" /><meta name="citation_date" content="2017/11/30" /><meta name="citation_author" content="Frances JD Smith" /><meta name="citation_author" content="C David Hansen" /><meta name="citation_author" content="Peter R Hull" /><meta name="citation_author" content="Roger L Kaspar" /><meta name="citation_author" content="WH Irwin McLean" /><meta name="citation_author" content="Edel O’Toole" /><meta name="citation_author" content="Eli Sprecher" /><meta name="citation_pmid" content="20301457" /><meta name="citation_fulltext_html_url" content="https://www.ncbi.nlm.nih.gov/books/NBK1280/" /><meta name="citation_keywords" content="Keratin, type I cytoskeletal 16" /><meta name="citation_keywords" content="Keratin, type I cytoskeletal 17" /><meta name="citation_keywords" content="Keratin, type II cytoskeletal 6A" /><meta name="citation_keywords" content="Keratin, type II cytoskeletal 6B" /><meta name="citation_keywords" content="Keratin, type II cytoskeletal 6C" /><meta name="citation_keywords" content="KRT16" /><meta name="citation_keywords" content="KRT17" /><meta name="citation_keywords" content="KRT6A" /><meta name="citation_keywords" content="KRT6B" /><meta name="citation_keywords" content="KRT6C" /><meta name="citation_keywords" content="Pachyonychia Congenita" /><link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /><meta name="DC.Title" content="Pachyonychia Congenita" /><meta name="DC.Type" content="Text" /><meta name="DC.Publisher" content="University of Washington, Seattle" /><meta name="DC.Contributor" content="Frances JD Smith" /><meta name="DC.Contributor" content="C David Hansen" /><meta name="DC.Contributor" content="Peter R Hull" /><meta name="DC.Contributor" content="Roger L Kaspar" /><meta name="DC.Contributor" content="WH Irwin McLean" /><meta name="DC.Contributor" content="Edel O’Toole" /><meta name="DC.Contributor" content="Eli Sprecher" /><meta name="DC.Date" content="2017/11/30" /><meta name="DC.Identifier" content="https://www.ncbi.nlm.nih.gov/books/NBK1280/" /><meta name="description" content="Pachyonychia congenita (PC) is characterized by hypertrophic nail dystrophy, painful palmoplantar keratoderma and blistering, oral leukokeratosis, pilosebaceous cysts (including steatocystoma and vellus hair cysts), palmoplantar hyperhydrosis, and follicular keratoses on the trunk and extremities." /><meta name="og:title" content="Pachyonychia Congenita" /><meta name="og:type" content="book" /><meta name="og:description" content="Pachyonychia congenita (PC) is characterized by hypertrophic nail dystrophy, painful palmoplantar keratoderma and blistering, oral leukokeratosis, pilosebaceous cysts (including steatocystoma and vellus hair cysts), palmoplantar hyperhydrosis, and follicular keratoses on the trunk and extremities." /><meta name="og:url" content="https://www.ncbi.nlm.nih.gov/books/NBK1280/" /><meta name="og:site_name" content="NCBI Bookshelf" /><meta name="og:image" content="https://www.ncbi.nlm.nih.gov/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-gene-lrg.png" /><meta name="twitter:card" content="summary" /><meta name="twitter:site" content="@ncbibooks" /><meta name="bk-non-canon-loc" content="/books/n/gene/pc/" /><link rel="canonical" href="https://www.ncbi.nlm.nih.gov/books/NBK1280/" /><link rel="stylesheet" href="/corehtml/pmc/css/figpopup.css" type="text/css" media="screen" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.22/css/books.min.css" type="text/css" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.22/css/books_print.min.css" type="text/css" media="print" /><style type="text/css">p a.figpopup{display:inline !important} .bk_tt {font-family: monospace}  .first-line-outdent .bk_ref {display: inline}  .body-content h2, .body-content .h2  {border-bottom: 1px solid #97B0C8} .body-content h2.inline {border-bottom: none} a.page-toc-label , .jig-ncbismoothscroll a {text-decoration:none;border:0 !important} .temp-labeled-list  .graphic {display:inline-block !important} .temp-labeled-list  img{width:100%}</style><script type="text/javascript" src="/corehtml/pmc/js/jquery.hoverIntent.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/common.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/large-obj-scrollbars.min.js"> </script><script type="text/javascript">window.name="mainwindow";</script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.22/book-toc.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.22/books.min.js"> </script><meta name="book-collection" content="NONE" />

        <!-- Page meta end -->
    <link rel="shortcut icon" href="//www.ncbi.nlm.nih.gov/favicon.ico" /><meta name="ncbi_phid" content="CE8903AFDFC85B810000000007400377.m_12" />
<meta name='referrer' content='origin-when-cross-origin'/><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/css/3852956/3985586/3808861/4121862/3974050/3917732/251717/4098876/14534/45193/4113719/3849091/3984811/3751656/4033350/3840896/3577051/3852958/4008682/3881636/3579733/4062871/12930/3964959/3854974/36029/4128070/9685/3549676/3609192/3609193/3609213/3395586.css" /><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/css/3411343/3882866.css" media="print" /></head>
    <body class="book-part">
        <div class="grid">
            <div class="col twelve_col nomargin shadow">
                <!-- System messages like service outage or JS required; this is handled by the TemplateResources portlet -->
                <div class="sysmessages">
                    <noscript>
	<p class="nojs">
	<strong>Warning:</strong>
	The NCBI web site requires JavaScript to function. 
	<a href="/guide/browsers/#enablejs" title="Learn how to enable JavaScript" target="_blank">more...</a>
	</p>
	</noscript>
                </div>
                <!--/.sysmessage-->
                <div class="wrap">
                    <div class="page">
                        <div class="top">
                            <div class="universal_header" id="universal_header"><ul class="inline_list jig-ncbimenu ui-ncbimenu resources_list" id="navcontent"><li class="ui-ncbimenu-item-leaf ui-ncbimenu-item-first ui-helper-reset ui-ncbimenu-item-no-hlt"><a class="ui-ncbimenu-link-first" href="/" role="banner" title="NCBI Home" id="ncbihome" accesskey="1"><span class="offscreen_noflow">NCBI</span><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/img/28977" class="ncbi_logo" title="NCBI" alt="NCBI Logo" /></a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#maincontent" title="Skip to the content" tabindex="0" accesskey="3">Skip to main
                        content</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#navcontent" title="Skip to the navigation" tabindex="0" accesskey="4">Skip to
                        navigation</a></li><li id="resource-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first ui-helper-reset"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#resources">Resources</a></li><li id="all-howtos-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#howto">How To</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="/guide/browsers/#accesskeys" title="About My NCBI Accesskeys" tabindex="0" accesskey="0">About NCBI Accesskeys</a></li></ul><div class="myncbi"><span id="myncbiusername" style="display:none"><a href="/account/settings/" id="mnu" title="Edit account settings"></a></span><a accesskey="2" href="/myncbi/" id="myncbi" style="display:none">My NCBI</a><a href="/account/" id="sign_in">Sign in to NCBI</a><a href="/account/signout/" id="sign_out" style="display:none">Sign Out</a></div></div>
                            <div class="header">
    <div class="res_logo"><h1 class="res_name"><a href="/books/" title="Bookshelf home">Bookshelf</a></h1><h2 class="res_tagline"></h2></div>
    <div class="search"><form method="get" action="/books/"><div class="search_form"><label for="database" class="offscreen_noflow">Search database</label><select id="database"><optgroup label="Recent"><option value="books" selected="selected" class="last" data-ac_dict="bookshelf-search">Books</option></optgroup><optgroup label="All"><option value="gquery">All Databases</option><option value="assembly">Assembly</option><option value="biocollections">Biocollections</option><option value="bioproject">BioProject</option><option value="biosample">BioSample</option><option value="biosystems">BioSystems</option><option value="books" data-ac_dict="bookshelf-search">Books</option><option value="clinvar">ClinVar</option><option value="cdd">Conserved Domains</option><option value="gap">dbGaP</option><option value="dbvar">dbVar</option><option value="gene">Gene</option><option value="genome">Genome</option><option value="gds">GEO DataSets</option><option value="geoprofiles">GEO Profiles</option><option value="gtr">GTR</option><option value="homologene">HomoloGene</option><option value="ipg">Identical Protein Groups</option><option value="medgen">MedGen</option><option value="mesh">MeSH</option><option value="ncbisearch">NCBI Web Site</option><option value="nlmcatalog">NLM Catalog</option><option value="nuccore">Nucleotide</option><option value="omim">OMIM</option><option value="pmc">PMC</option><option value="popset">PopSet</option><option value="probe">Probe</option><option value="protein">Protein</option><option value="proteinclusters">Protein Clusters</option><option value="pcassay">PubChem BioAssay</option><option value="pccompound">PubChem Compound</option><option value="pcsubstance">PubChem Substance</option><option value="pubmed">PubMed</option><option value="snp">SNP</option><option value="sparcle">Sparcle</option><option value="sra">SRA</option><option value="structure">Structure</option><option value="taxonomy">Taxonomy</option><option value="toolkit">ToolKit</option><option value="toolkitall">ToolKitAll</option><option value="toolkitbookgh">ToolKitBookgh</option></optgroup></select><div class="nowrap"><label for="term" class="offscreen_noflow" accesskey="/">Search term</label><div class="nowrap"><input type="text" name="term" id="term" title="Search Books. Use up and down arrows to choose an item from the autocomplete." value="" class="jig-ncbiclearbutton jig-ncbiautocomplete" data-jigconfig="dictionary:'bookshelf-search',disableUrl:'NcbiSearchBarAutoComplCtrl'" autocomplete="off" data-sbconfig="ds:'no',pjs:'no',afs:'no'" /></div><button id="search" type="submit" class="button_search nowrap" cmd="go">Search</button></div></div></form><ul class="searchlinks inline_list"><li>
                        <a href="/books/browse/">Browse Titles</a>
                    </li><li>
                        <a href="/books/advanced/">Advanced</a>
                    </li><li class="help">
                        <a href="/books/NBK3833/">Help</a>
                    </li></ul></div>
</div>

                            
                            
                        <!--<component id="Page" label="headcontent"/>-->
                            
                        </div>
                        <div class="content">
                            <!-- site messages -->
                            <!-- Custom content 1 -->
<div class="col1">
    
</div>

<div class="container">
    <div id="maincontent" class="content eight_col col">
        <!-- Custom content in the left column above book nav -->
        <div class="col2">
            
        </div>
        
        <!-- Book content -->
        

        <!-- Custom content between navigation and content -->
        <div class="col3">
            
        </div>
        
        <div class="document">
            <div class="pre-content"><div><div class="bk_prnt"><p class="small">NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.</p><p>Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2019. </p></div><div class="iconblock clearfix whole_rhythm no_top_margin bk_noprnt"><a class="img_link icnblk_img" title="All GeneReviews" href="/books/n/gene/"><img class="source-thumb" src="/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-gene-lrg.png" alt="Cover of GeneReviews®" height="100px" width="80px" /></a><div class="icnblk_cntnt eight_col"><h2>GeneReviews<sup>®</sup> [Internet].</h2><a data-jig="ncbitoggler" href="#__NBK1280_dtls__">Show details</a><div style="display:none" class="ui-widget" id="__NBK1280_dtls__"><div>Adam MP, Ardinger HH, Pagon RA, et al., editors.</div><div>Seattle (WA): <a href="http://www.washington.edu" ref="pagearea=page-banner&amp;targetsite=external&amp;targetcat=link&amp;targettype=publisher">University of Washington, Seattle</a>; 1993-2019.</div></div><div class="half_rhythm"><ul class="inline_list"><li style="margin-right:1em"><a class="bk_cntns" href="/books/n/gene/">GeneReviews by Title</a></li></ul></div><div class="bk_noprnt"><form method="get" action="/books/n/gene/" id="bk_srch"><div class="bk_search"><label for="bk_term" class="offscreen_noflow">Search term</label><input type="text" title="Search GeneReviews" id="bk_term" name="term" value="" data-jig="ncbiclearbutton" /> <input type="submit" class="jig-ncbibutton" value="Search GeneReviews" submit="false" style="padding: 0.1em 0.4em;" /></div></form><div><ul class="inline_list"><li><a href="/books/n/gene/advanced/">GeneReviews Advanced Search</a></li><li style="margin-left:.5em"><a href="/books/n/gene/helpadvsearch/">Help</a></li></ul></div></div></div><div class="icnblk_cntnt two_col"><div class="pagination bk_noprnt"><a class="active page_link prev" href="/books/n/gene/pura-dis/" title="Previous page in this title">&lt; Prev</a><a class="active page_link next" href="/books/n/gene/phs/" title="Next page in this title">Next &gt;</a></div></div></div></div></div>
            <div class="main-content lit-style" itemscope="itemscope" itemtype="http://schema.org/CreativeWork"><div class="meta-content fm-sec"><h1 id="_NBK1280_"><span class="title" itemprop="name">Pachyonychia Congenita</span></h1><p class="contrib-group"><span itemprop="author">Frances JD Smith</span>, PhD, <span itemprop="author">C David Hansen</span>, MD, <span itemprop="author">Peter R Hull</span>, MD, PhD, FRCPC, <span itemprop="author">Roger L Kaspar</span>, PhD, <span itemprop="author">WH Irwin McLean</span>, DSc, FRSE, <span itemprop="author">Edel O&#x02019;Toole</span>, MD, PhD, FRCPI, FRCP, and <span itemprop="author">Eli Sprecher</span>, MD, PhD.</p><a data-jig="ncbitoggler" href="#__NBK1280_ai__" style="border:0;text-decoration:none">Author Information</a><div style="display:none" class="ui-widget" id="__NBK1280_ai__"><div class="contrib half_rhythm"><span itemprop="author">Frances JD Smith</span>, PhD<div class="affiliation small">Pachyonychia Congenita Project<br />School of Life Sciences<br />University of Dundee<br />Dundee, Scotland, United Kingdom<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="gro.aihcynoyhcap@htims.secnarf" class="oemail">gro.aihcynoyhcap@htims.secnarf</a></div></div></div><div class="contrib half_rhythm"><span itemprop="author">C David Hansen</span>, MD<div class="affiliation small">Department of Dermatology<br />University of Utah<br />Salt Lake City, Utah<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="ude.hatu.csh@nesnah.divad" class="oemail">ude.hatu.csh@nesnah.divad</a></div></div></div><div class="contrib half_rhythm"><span itemprop="author">Peter R Hull</span>, MD, PhD, FRCPC<div class="affiliation small">Division of Clinical Dermatology and Cutaneoous Science<br />Dalhousie University<br />Halifax, Nova Scotia, Canada<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="ac.lad@lluh.retep" class="oemail">ac.lad@lluh.retep</a></div></div></div><div class="contrib half_rhythm"><span itemprop="author">Roger L Kaspar</span>, PhD<div class="affiliation small">Transderm, Inc<br />Santa Cruz, California<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="moc.cnimredsnart@rapsak.regor" class="oemail">moc.cnimredsnart@rapsak.regor</a></div></div></div><div class="contrib half_rhythm"><span itemprop="author">WH Irwin McLean</span>, DSc, FRSE<div class="affiliation small">Division of Biological Chemistry and Drug Discovery<br />School of Life Sciences<br />University of Dundee<br />Dundee, Scotland, United Kingdom<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="ku.ca.eednud@naelcm.i.h.w" class="oemail">ku.ca.eednud@naelcm.i.h.w</a></div></div></div><div class="contrib half_rhythm"><span itemprop="author">Edel O&#x02019;Toole</span>, MD, PhD, FRCPI, FRCP<div class="affiliation small">Centre for Cutaneous Research<br />Barts &#x00026; the London School of Medicine and Dentistry<br />Queen Mary University of London<br />London, England, United Kingdom<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="ku.ca.lumq@elooto.a.e" class="oemail">ku.ca.lumq@elooto.a.e</a></div></div></div><div class="contrib half_rhythm"><span itemprop="author">Eli Sprecher</span>, MD, PhD<div class="affiliation small">Department of Dermatology<br />Tel Aviv Medical Center<br />Tel Aviv, Israel<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="li.vog.cmvlt@psile" class="oemail">li.vog.cmvlt@psile</a></div></div></div></div><p class="small">Initial Posting: <span itemprop="datePublished">January 27, 2006</span>; Last Update: <span itemprop="dateModified">November 30, 2017</span>.</p><p><em>Estimated reading time: 26 minutes</em></p></div><div class="jig-ncbiinpagenav body-content whole_rhythm" data-jigconfig="allHeadingLevels: ['h2'],smoothScroll: false" itemprop="text"><div id="pc.Summary" itemprop="description"><h2 id="_pc_Summary_">Summary</h2><div><h4 class="inline">Clinical characteristics.</h4><p>Pachyonychia congenita (PC) is characterized by hypertrophic nail dystrophy, painful palmoplantar keratoderma and blistering, oral leukokeratosis, pilosebaceous cysts (including steatocystoma and vellus hair cysts), palmoplantar hyperhydrosis, and follicular keratoses on the trunk and extremities.</p></div><div><h4 class="inline">Diagnosis/testing.</h4><p>PC is diagnosed by clinical findings and/or by the identification of a <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in one of the five keratin genes known to cause PC: <i>KRT6A</i>, <i>KRT6B</i>, <i>KRT6C</i>, <i>KRT16</i>, and <i>KRT17</i>.</p></div><div><h4 class="inline">Management.</h4><p><i>Treatment of manifestations:</i> Pain from the palmoplantar keratoderma may be reduced somewhat by limiting friction and trauma to the feet by minimizing walking or standing, reducing hydration of the stratum corneum by using wicking socks and ventilated footwear, selecting comfortable shoes, and maintaining ideal body weight. Foot care includes paring down of hyperkeratotic areas and topical therapies for hyperkeratosis (emollients and lotions containing keratolyics). Care of thickened nails often requires the use of surgical or razor blades or sanders such as a Dremel<sup>&#x000ae;</sup> tool. Troublesome nails removed surgically frequently grow back in some form. Good oral hygiene and brushing gently with a soft toothbrush can improve thick, white patches on the tongue and oral mucosa. Secondary fungal and bacterial infections that require treatment are common; cysts usually do not require treatment but can be incised and drained if infected or painful. Bottle-fed infants with leukokeratosis may need a soft nipple with an enlarged opening. Rarely, young children with laryngeal thickening/growths need emergency surgery to reestablish the airway; however, surgery may exacerbate the condition.</p><p><i>Prevention of secondary complications:</i> Attention to pre- and post-grooming hygiene to prevent infection; a "bleach bath" regimen using a mild bleach solution can help prevent infections.</p><p><i>Agents/circumstances to avoid:</i> High temperatures and high humidity may worsen the condition.</p></div><div><h4 class="inline">Genetic counseling.</h4><p>Pachyonychia congenita is inherited in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> manner. Approximately 30% of cases appear to be caused by a <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>. A single case of <a class="def" href="/books/n/gene/glossary/def-item/germline-mosaicism/">germline mosaicism</a> has been reported. The offspring of an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual have a 50% chance of inheriting the disorder. If the pathogenic variant has been identified in an affected family member, prenatal testing for a pregnancy at increased risk is possible.</p></div></div><div id="pc.Diagnosis"><h2 id="_pc_Diagnosis_">Diagnosis</h2><p>Clinical diagnostic criteria for pachyonychia congenita (PC) include the triad of toenail thickening, plantar keratoderma, and plantar pain, which is present in 97% of individuals with genetically confirmed PC by age ten years [<a href="http://www.pachyonychia.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">International Pachyonychia Research Registry</a>, <a class="bk_pop" href="#pc.REF.eliason.2012.680">Eliason et al 2012</a>].</p><div id="pc.Suggestive_Findings"><h3>Suggestive Findings</h3><p>Pachyonychia congenita (PC) <b>should be suspected</b> in individuals with the following clinical features and/or family history findings.</p><p><b>Clinical features</b></p><ul><li class="half_rhythm"><div>Plantar keratoderma including callus with underlying blisters</div></li><li class="half_rhythm"><div>Plantar pain</div></li><li class="half_rhythm"><div>Hypertrophic nail dystrophy, which may be limited to the toenails or to a few toenails or fingernails (See <a class="figpopup" href="/books/NBK1280/figure/pc.F1/?report=objectonly" target="object" rid-figpopup="figpcF1" rid-ob="figobpcF1">Figure 1</a> and <a class="figpopup" href="/books/NBK1280/table/pc.T.international_pachyonychia_congenit/?report=objectonly" target="object" rid-figpopup="figpcTinternationalpachyonychiacongenit" rid-ob="figobpcTinternationalpachyonychiacongenit">Table 2</a>.)</div></li><li class="half_rhythm"><div>Pilosebaceous cysts including widespread steatocystomas/steatocysts (benign lesions) and vellus hair cysts which usually develop at puberty and continue throughout adulthood</div></li><li class="half_rhythm"><div>Oral leukokeratosis</div></li><li class="half_rhythm"><div>Follicular keratoses on the trunk and extremities usually present by early childhood</div></li><li class="half_rhythm"><div>Palmoplantar hyperhydrosis (&#x0003c;50%)</div></li><li class="half_rhythm"><div>Natal or prenatal teeth (i.e., present at birth or by age 1 month in some <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals)</div></li></ul><div class="iconblock whole_rhythm clearfix ten_col fig" id="figpcF1" co-legend-rid="figlgndpcF1"><a href="/books/NBK1280/figure/pc.F1/?report=objectonly" target="object" title="Figure 1. " class="img_link icnblk_img figpopup" rid-figpopup="figpcF1" rid-ob="figobpcF1"><img class="small-thumb" src="/books/NBK1280/bin/pc-Image001.gif" src-large="/books/NBK1280/bin/pc-Image001.jpg" alt="Figure 1. . Common findings of pachyonychia congenita include: thickened and dystrophic nails (both fingernails and toenails) (a-c); bullae (usually on the pressure points of the heels and soles); hyperkeratosis (d-e); cysts (f); and oral leukokeratosis (g)." /></a><div class="icnblk_cntnt" id="figlgndpcF1"><h4 id="pc.F1"><a href="/books/NBK1280/figure/pc.F1/?report=objectonly" target="object" rid-ob="figobpcF1">Figure 1. </a></h4><p class="float-caption no_bottom_margin">Common findings of pachyonychia congenita include: thickened and dystrophic nails (both fingernails and toenails) (a-c); bullae (usually on the pressure points of the heels and soles); hyperkeratosis (d-e); cysts (f); and oral leukokeratosis (g). </p></div></div><p><b>Family history</b> consistent with <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> inheritance</p><p>Note: (1) Approximately 70% of individuals with PC, enrolled in the International Pachyonychia Congenita Research Registry, inherited the condition from an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> parent; therefore, lack of a family history of PC does not preclude the diagnosis. (2) If the family history suggests <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> inheritance, a condition other than PC should be considered (see <a href="#pc.Differential_Diagnosis">Differential Diagnosis</a>).</p></div><div id="pc.Establishing_the_Diagnosis"><h3>Establishing the Diagnosis</h3><p>The diagnosis of PC <b>is established</b> in a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> with the triad of toenail thickening, plantar keratoderma, and plantar pain and/or by the identification of a <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in one of the five genes listed in <a class="figpopup" href="/books/NBK1280/table/pc.T.molecular_genetic_testing_used_in_p/?report=objectonly" target="object" rid-figpopup="figpcTmoleculargenetictestingusedinp" rid-ob="figobpcTmoleculargenetictestingusedinp">Table 1</a>.</p><p>Note: Histologic, immunohistologic, or electron microscopic examination of the nails or skin from individuals with PC is not helpful in confirming the diagnosis of PC but can be performed to rule out other diagnoses.</p><p>Molecular genetic testing approaches can include <b>serial single-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> testing</b>, use of a <b><a class="def" href="/books/n/gene/glossary/def-item/multigene-panel/">multigene panel</a></b>, and <b>more comprehensive</b>
<b><a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> testing</b>.</p><p><b>Serial single-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> testing</b></p><ul><li class="half_rhythm"><div>For individuals who have focal non-epidermolytic palmoplantar keratoderma (FNEPPK), <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a> of <i>KRT6C</i> and <i>KRT16</i> may be considered first.</div></li><li class="half_rhythm"><div>For individuals who have steatocystoma multiplex (SM) or a history of natal teeth, <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a> of <i>KRT17</i> may be considered first.</div></li></ul><p><b>A <a class="def" href="/books/n/gene/glossary/def-item/multigene-panel/">multigene panel</a></b> that includes <i>KRT6A</i>, <i>KRT6B</i>, <i>KRT6C</i>, <i>KRT16</i>, <i>KRT17</i>, and other genes of interest (see <a href="#pc.Differential_Diagnosis">Differential Diagnosis</a>) may also be considered. Note: (1) The genes included in the panel and the diagnostic <a class="def" href="/books/n/gene/glossary/def-item/sensitivity/">sensitivity</a> of the testing used for each <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> varies by laboratory and are likely to change over time. (2) Some multigene panels may include genes not associated with the condition discussed in this <i>GeneReview</i>; thus, clinicians need to determine which multigene panel is most likely to identify the genetic cause of the condition at the most reasonable cost while limiting identification of variants of <a class="def" href="/books/n/gene/glossary/def-item/uncertain-significance/">uncertain significance</a> and pathogenic variants in genes that do not explain the underlying <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a>. (3) In some laboratories, panel options may include a custom laboratory-designed panel and/or custom phenotype-focused <a class="def" href="/books/n/gene/glossary/def-item/exome/">exome</a> analysis that includes genes specified by the clinician. (4) Methods used in a panel may include <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a>, <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a>, and/or other non-sequencing-based tests.</p><p>For an introduction to multigene panels click <a href="/books/n/gene/app5/#app5.Multigene_Panels">here</a>. More detailed information for clinicians ordering genetic tests can be found <a href="/books/n/gene/app5/#app5.Multigene_Panels_FAQs">here</a>.</p><p><b>More comprehensive <a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> testing</b> (when available) including <a class="def" href="/books/n/gene/glossary/def-item/exome-sequencing/">exome sequencing</a> and <a class="def" href="/books/n/gene/glossary/def-item/genome-sequencing/">genome sequencing</a> may be considered. Such testing may provide or suggest a diagnosis not previously considered (e.g., mutation of a different <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> or genes that results in a similar clinical presentation). For an introduction to comprehensive genomic testing click <a href="/books/n/gene/app5/#app5.Comprehensive_Genomic_Testing">here</a>. More detailed information for clinicians ordering genomic testing can be found <a href="/books/n/gene/app5/#app5.Comprehensive_Genomic_Testing_1">here</a>.</p><div id="pc.T.molecular_genetic_testing_used_in_p" class="table"><h3><span class="label">Table 1. </span></h3><div class="caption"><p>Molecular Genetic Testing Used in Pachyonychia Congenita (PC)</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1280/table/pc.T.molecular_genetic_testing_used_in_p/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__pc.T.molecular_genetic_testing_used_in_p_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_pc.T.molecular_genetic_testing_used_in_p_1_1_1_1" rowspan="2" scope="col" colspan="1" headers="hd_h_pc.T.molecular_genetic_testing_used_in_p_1_1_1_1" style="text-align:left;vertical-align:middle;">Gene&#x000a0;<sup>1</sup></th><th id="hd_h_pc.T.molecular_genetic_testing_used_in_p_1_1_1_2" rowspan="2" scope="col" colspan="1" headers="hd_h_pc.T.molecular_genetic_testing_used_in_p_1_1_1_2" style="text-align:left;vertical-align:middle;">Proportion of PC Attributed to Pathogenic Variants in Gene&#x000a0;<sup>2,&#x000a0;3</sup></th><th id="hd_h_pc.T.molecular_genetic_testing_used_in_p_1_1_1_3" colspan="2" scope="colgroup" rowspan="1" style="text-align:left;vertical-align:middle;">Proportion of Pathogenic Variants&#x000a0;<sup>4</sup> Detectable by Method</th></tr><tr><th headers="hd_h_pc.T.molecular_genetic_testing_used_in_p_1_1_1_3" id="hd_h_pc.T.molecular_genetic_testing_used_in_p_1_1_2_1" colspan="1" scope="colgroup" rowspan="1" style="text-align:left;vertical-align:middle;">Sequence analysis&#x000a0;<sup>5</sup></th><th headers="hd_h_pc.T.molecular_genetic_testing_used_in_p_1_1_1_3" id="hd_h_pc.T.molecular_genetic_testing_used_in_p_1_1_2_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Gene-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a>&#x000a0;<sup>6</sup></th></tr></thead><tbody><tr><td headers="hd_h_pc.T.molecular_genetic_testing_used_in_p_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>KRT6A</i></td><td headers="hd_h_pc.T.molecular_genetic_testing_used_in_p_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">304/774 (39%)</td><td headers="hd_h_pc.T.molecular_genetic_testing_used_in_p_1_1_1_3 hd_h_pc.T.molecular_genetic_testing_used_in_p_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">&#x0003e;99%</td><td headers="hd_h_pc.T.molecular_genetic_testing_used_in_p_1_1_1_3 hd_h_pc.T.molecular_genetic_testing_used_in_p_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Unknown&#x000a0;<sup>7</sup></td></tr><tr><td headers="hd_h_pc.T.molecular_genetic_testing_used_in_p_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>KRT6B</i></td><td headers="hd_h_pc.T.molecular_genetic_testing_used_in_p_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">70/774 (9%)</td><td headers="hd_h_pc.T.molecular_genetic_testing_used_in_p_1_1_1_3 hd_h_pc.T.molecular_genetic_testing_used_in_p_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">&#x0003e;99%</td><td headers="hd_h_pc.T.molecular_genetic_testing_used_in_p_1_1_1_3 hd_h_pc.T.molecular_genetic_testing_used_in_p_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Unknown&#x000a0;<sup>7</sup></td></tr><tr><td headers="hd_h_pc.T.molecular_genetic_testing_used_in_p_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>KRT6C</i></td><td headers="hd_h_pc.T.molecular_genetic_testing_used_in_p_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">22/774 (3%)</td><td headers="hd_h_pc.T.molecular_genetic_testing_used_in_p_1_1_1_3 hd_h_pc.T.molecular_genetic_testing_used_in_p_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">&#x0003e;99%</td><td headers="hd_h_pc.T.molecular_genetic_testing_used_in_p_1_1_1_3 hd_h_pc.T.molecular_genetic_testing_used_in_p_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Unknown&#x000a0;<sup>7</sup></td></tr><tr><td headers="hd_h_pc.T.molecular_genetic_testing_used_in_p_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>KRT16</i></td><td headers="hd_h_pc.T.molecular_genetic_testing_used_in_p_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">247/774 (32%)</td><td headers="hd_h_pc.T.molecular_genetic_testing_used_in_p_1_1_1_3 hd_h_pc.T.molecular_genetic_testing_used_in_p_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">&#x0003e;99%</td><td headers="hd_h_pc.T.molecular_genetic_testing_used_in_p_1_1_1_3 hd_h_pc.T.molecular_genetic_testing_used_in_p_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Unknown&#x000a0;<sup>7</sup></td></tr><tr><td headers="hd_h_pc.T.molecular_genetic_testing_used_in_p_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>KRT17</i>&#x000a0;<sup>8</sup></td><td headers="hd_h_pc.T.molecular_genetic_testing_used_in_p_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">130/774 (17%)</td><td headers="hd_h_pc.T.molecular_genetic_testing_used_in_p_1_1_1_3 hd_h_pc.T.molecular_genetic_testing_used_in_p_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">&#x0003e;99%</td><td headers="hd_h_pc.T.molecular_genetic_testing_used_in_p_1_1_1_3 hd_h_pc.T.molecular_genetic_testing_used_in_p_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Unknown&#x000a0;<sup>7</sup></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt>1. </dt><dd><div id="pc.TF.1.1"><p class="no_margin">See <a href="/books/NBK1280/#pc.molgen.TA">Table A. Genes and Databases</a> for <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a> and protein.</p></div></dd><dt>2. </dt><dd><div id="pc.TF.1.2"><p class="no_margin">Pathogenic variants in at least 800 individuals have been reported [<a href="http://www.pachyonychia.org/patient-registry/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">International PC Research Registry</a>, <a href="/books/NBK1280/#pc.molgen.TA">Human Intermediate Filament Database</a>].</p></div></dd><dt>3. </dt><dd><div id="pc.TF.1.3"><p class="no_margin">The numbers in this table refer only to those individuals enrolled in the <a href="http://www.pachyonychia.org/patient-registry/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">International PC Research Registry</a> (IPCRR); not all are published but the data are available on the website.</p></div></dd><dt>4. </dt><dd><div id="pc.TF.1.4"><p class="no_margin">See <a href="#pc.Molecular_Genetics">Molecular Genetics</a> for information on allelic variants detected in this <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>.</p></div></dd><dt>5. </dt><dd><div id="pc.TF.1.5"><p class="no_margin">Sequence analysis detects variants that are benign, likely benign, of <a class="def" href="/books/n/gene/glossary/def-item/uncertain-significance/">uncertain significance</a>, likely pathogenic, or pathogenic. Pathogenic variants may include small intragenic deletions/insertions and <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a>, <a class="def" href="/books/n/gene/glossary/def-item/nonsense-variant/">nonsense</a>, and <a class="def" href="/books/n/gene/glossary/def-item/splice-site/">splice site</a> variants; typically, <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> or whole-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> deletions/duplications are not detected. For issues to consider in interpretation of <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a> results, click <a href="/books/n/gene/app2/">here</a>.</p></div></dd><dt>6. </dt><dd><div id="pc.TF.1.6"><p class="no_margin">Gene-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a> detects intragenic deletions or duplications. Methods used may include <a class="def" href="/books/n/gene/glossary/def-item/quantitative-pcr/">quantitative PCR</a>, long-range PCR, multiplex ligation-dependent probe amplification (MLPA), and a <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>-targeted microarray designed to detect single-<a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> deletions or duplications.</p></div></dd><dt>7. </dt><dd><div id="pc.TF.1.7"><p class="no_margin">No data on <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>-targeted del/dup analysis are available.</p></div></dd><dt>8. </dt><dd><div id="pc.TF.1.8"><p class="no_margin">To date all identified pathogenic variants causing steatocystoma multiplex (SM) are in <i>KRT17.</i> Careful reexamination of those with SM caused by a <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> <i>KRT17</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> have identified subtle nail changes in some family members. Many individuals with a clinical diagnosis of SM and no nails changes also have no identifiable pathogenic variant in <i>KRT17</i>. Therefore, genetic heterogeneity is likely for SM.</p></div></dd></dl></div></div></div></div></div><div id="pc.Clinical_Characteristics"><h2 id="_pc_Clinical_Characteristics_">Clinical Characteristics</h2><div id="pc.Clinical_Description"><h3>Clinical Description</h3><p>In all types of pachyonychia congenita (PC) most characteristics are visible by age ten years [<a class="bk_pop" href="#pc.REF.shah.2014.146">Shah et al 2014</a>] and typically include toenail thickening, plantar keratoderma, and plantar pain (see <a href="#pc.Suggestive_Findings">Suggestive Findings</a>). However, the absence or presence of certain features as well as the age at onset varies according the <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> that is mutated (see <a class="figpopup" href="/books/NBK1280/table/pc.T.international_pachyonychia_congenit/?report=objectonly" target="object" rid-figpopup="figpcTinternationalpachyonychiacongenit" rid-ob="figobpcTinternationalpachyonychiacongenit">Table 2</a> for phenotypic features of PC). The most recent classification of the condition also incorporates the genetic cause (see <a href="#pc.Nomenclature">Nomenclature</a>).</p><p>The severity of findings can differ both within a family and among families with the same <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>.</p><div id="pc.T.international_pachyonychia_congenit" class="table"><h3><span class="label">Table 2. </span></h3><div class="caption"><p>International Pachyonychia Congenita Research Registry (IPCRR) Data Summary (as of 10 May 2017)</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1280/table/pc.T.international_pachyonychia_congenit/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__pc.T.international_pachyonychia_congenit_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_1" colspan="2" scope="colgroup" rowspan="1" style="text-align:left;vertical-align:middle;">Gene in Which Pathogenic<br />Variants Were Confirmed</th><th id="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>KRT6A</i></th><th id="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>KRT6B</i></th><th id="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_4" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>KRT6C</i></th><th id="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_5" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>KRT16</i></th><th id="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_6" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>KRT17</i></th><th id="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_7" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">TOTAL</th></tr></thead><tbody><tr><td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_1" colspan="2" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;"><b>Number evaluated for finding&#x000a0;<sup>1</sup></b></td><td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">304</td><td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">71</td><td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">22</td><td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">247</td><td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_6" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">130</td><td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_7" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">774</td></tr><tr><td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_1 hd_h_pc.T.international_pachyonychia_congenit_1_1_1_2 hd_h_pc.T.international_pachyonychia_congenit_1_1_1_3 hd_h_pc.T.international_pachyonychia_congenit_1_1_1_4 hd_h_pc.T.international_pachyonychia_congenit_1_1_1_5 hd_h_pc.T.international_pachyonychia_congenit_1_1_1_6 hd_h_pc.T.international_pachyonychia_congenit_1_1_1_7" colspan="8" scope="col" rowspan="1" style="text-align:left;vertical-align:middle;"><b>Toenails thickened</b></td></tr><tr><td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_1" colspan="2" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">10 toenails</td><td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">286 (94%)</td><td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">26 (37%)</td><td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">0 (00%)</td><td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">99 (40%)</td><td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_6" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">100 (77%)</td><td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_7" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">511 (66%)</td></tr><tr><td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_1" colspan="2" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">7-9 toenails</td><td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">9 (03%)</td><td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">14 (20%)</td><td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">0 (00%)</td><td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">52 (21%)</td><td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_6" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">11 (08%)</td><td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_7" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">86 (11%)</td></tr><tr><td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_1" colspan="2" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">4-6 toenails</td><td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">2 (01%)</td><td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">21 (30%)</td><td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">3 (14%)</td><td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">63 (26%)</td><td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_6" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">7 (05%)</td><td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_7" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">96 (12%)</td></tr><tr><td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_1" colspan="2" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">1-3 toenails</td><td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">4 (01%)</td><td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">9 (13%)</td><td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">10 (45%)</td><td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">44 (18%)</td><td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_6" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">8 (06%)</td><td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_7" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">75 (10%)</td></tr><tr><td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_1" colspan="2" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;"><b>Total w/toenails thickened</b></td><td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>301 (99%)</b></td><td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>70 (99%)</b></td><td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>13 (59%)</b></td><td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>238 (96%)</b></td><td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_6" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>126 (97%)</b></td><td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_7" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>748 (97%)</b></td></tr><tr><td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_1" rowspan="4" scope="row" colspan="1" style="text-align:left;vertical-align:middle;"><b>Age</b><br /><b>at</b><br /><b>onset</b></td><td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Birth - &#x0003c;1 yr</td><td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">264 (88%)</td><td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">10 (14%)</td><td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">1 (08%)</td><td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">45 (19%)</td><td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_6" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">92 (73%)</td><td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_7" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">412 (54%)</td></tr><tr><td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_1" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">1-4 yrs</td><td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">33 (11%)</td><td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">19 (27%)</td><td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">6 (46%)</td><td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">78 (33%)</td><td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_6" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">24 (19%)</td><td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_7" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">160 (21%)</td></tr><tr><td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_1" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">5-14 yrs</td><td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">4 (01%)</td><td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">34 (49%)</td><td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">4 (31%)</td><td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">74 (31%)</td><td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_6" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">10 (08%)</td><td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_7" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">126 (17%)</td></tr><tr><td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_1" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">&#x02265;15 yrs</td><td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">0 (00%)</td><td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">7 (10%)</td><td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">2 (15%)</td><td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">43 (18%)</td><td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_6" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">1 (01%)</td><td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_7" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">53 (07%)</td></tr><tr><td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_1 hd_h_pc.T.international_pachyonychia_congenit_1_1_1_2 hd_h_pc.T.international_pachyonychia_congenit_1_1_1_3 hd_h_pc.T.international_pachyonychia_congenit_1_1_1_4 hd_h_pc.T.international_pachyonychia_congenit_1_1_1_5 hd_h_pc.T.international_pachyonychia_congenit_1_1_1_6 hd_h_pc.T.international_pachyonychia_congenit_1_1_1_7" colspan="8" scope="col" rowspan="1" style="text-align:left;vertical-align:middle;"><b>Fingernails thickened</b></td></tr><tr><td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_1" colspan="2" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">10 fingernails</td><td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">271 (89%)</td><td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">4 (06%)</td><td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">0 (00%)</td><td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">73 (30%)</td><td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_6" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">62 (48%)</td><td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_7" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">410 (53%)</td></tr><tr><td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_1" colspan="2" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">7-9 fingernails</td><td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">10 (03%)</td><td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">4 (06%)</td><td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">0 (00%)</td><td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">11 (04%)</td><td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_6" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">13 (10%)</td><td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_7" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">38 (05%)</td></tr><tr><td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_1" colspan="2" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">4-6 fingernails</td><td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">14 (05%)</td><td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">17 (24%)</td><td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">0 (00%)</td><td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">30 (12%)</td><td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_6" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">28 (22%)</td><td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_7" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">89 (11%)</td></tr><tr><td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_1" colspan="2" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">1-3 fingernails</td><td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">6 (02%)</td><td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">7 (10%)</td><td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">0 (00%)</td><td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">28 (11%)</td><td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_6" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">9 (07%)</td><td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_7" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">50 (06%)</td></tr><tr><td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_1" colspan="2" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;"><b>Total w/fingernails thickened</b></td><td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>301 (99%)</b></td><td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>32 (45%)</b></td><td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>0 (00%)</b></td><td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>142 (57%)</b></td><td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_6" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>112 (86%)</b></td><td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_7" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>587 (76%)</b></td></tr><tr><td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_1" rowspan="4" scope="row" colspan="1" style="text-align:left;vertical-align:middle;"><b>Age</b><br /><b>at</b><br /><b>onset</b></td><td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Birth - &#x0003c;1 yr</td><td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">267 (89%)</td><td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">4 (13%)</td><td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">0 (00%)</td><td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">33 (23%)</td><td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_6" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">85 (76%)</td><td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_7" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">389 (66%)</td></tr><tr><td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_1" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">1-4 yrs</td><td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">30 (10%)</td><td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">8 (25%)</td><td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">0 (00%)</td><td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">42 (30%)</td><td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_6" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">19 (17%)</td><td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_7" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">99 (17%)</td></tr><tr><td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_1" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">5-14 yrs</td><td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">3 (01%)</td><td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">11 (34%)</td><td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">0 (00%)</td><td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">34 (24%)</td><td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_6" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">6 (05%)</td><td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_7" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">54 (09%)</td></tr><tr><td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_1" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">&#x02265;15 yrs</td><td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">1 (00%)</td><td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">10 (31%)</td><td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">0 (00%)</td><td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">34 (24%)</td><td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_6" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">3 (03%)</td><td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_7" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">48 (08%)</td></tr><tr><td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_1 hd_h_pc.T.international_pachyonychia_congenit_1_1_1_2 hd_h_pc.T.international_pachyonychia_congenit_1_1_1_3 hd_h_pc.T.international_pachyonychia_congenit_1_1_1_4 hd_h_pc.T.international_pachyonychia_congenit_1_1_1_5 hd_h_pc.T.international_pachyonychia_congenit_1_1_1_6 hd_h_pc.T.international_pachyonychia_congenit_1_1_1_7" colspan="8" scope="col" rowspan="1" style="text-align:left;vertical-align:middle;"><b>Plantar keratoderma</b></td></tr><tr><td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_1" colspan="2" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Always (never completely goes away)</td><td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">254 (84%)</td><td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">67 (94%)</td><td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">19 (86%)</td><td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">240 (97%)</td><td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_6" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">86 (66%)</td><td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_7" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">666 (86%)</td></tr><tr><td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_1" colspan="2" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Sometimes (feet clear up completely at times)</td><td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">7 (02%)</td><td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">1 (01%)</td><td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">0 (00%)</td><td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">1 (00%)</td><td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_6" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">14 (11%)</td><td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_7" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">23 (03%)</td></tr><tr><td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_1" colspan="2" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Seldom (feet usually clear of symptoms)</td><td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">5 (02%)</td><td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">0 (00%)</td><td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">0 (00%)</td><td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">0 (00%)</td><td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_6" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">4 (03%)</td><td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_7" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">9 (01%)</td></tr><tr><td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_1" colspan="2" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;"><b>Total w/plantar keratoderma</b></td><td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>266 (88%)</b></td><td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>68 (96%)</b></td><td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>19 (86%)</b></td><td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>241 (98%)</b></td><td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_6" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>104 (80%)</b></td><td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_7" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>698 (90%)</b></td></tr><tr><td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_1" rowspan="4" scope="row" colspan="1" style="text-align:left;vertical-align:middle;"><b>Age</b><br /><b>at</b><br /><b>onset</b></td><td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Birth - &#x0003c;1 yr</td><td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">39 (15%)</td><td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">2 (03%)</td><td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">1 (05%)</td><td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">23 (10%)</td><td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_6" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">12 (12%)</td><td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_7" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">77 (11%)</td></tr><tr><td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_1" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">1-4 yrs</td><td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">152 (57%)</td><td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">23 (34%)</td><td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">9 (47%)</td><td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">130 (54%)</td><td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_6" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">35 (34%)</td><td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_7" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">349 (50%)</td></tr><tr><td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_1" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">5-14 yrs</td><td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">70 (26%)</td><td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">42 (62%)</td><td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">9 (47%)</td><td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">82 (34%)</td><td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_6" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">43 (41%)</td><td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_7" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">246 (35%)</td></tr><tr><td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_1" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">&#x02265;15 yrs</td><td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">5 (02%)</td><td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">1 (01%)</td><td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">0 (00%)</td><td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">8 (03%)</td><td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_6" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">15 (14%)</td><td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_7" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">29 (04%)</td></tr><tr><td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_1 hd_h_pc.T.international_pachyonychia_congenit_1_1_1_2 hd_h_pc.T.international_pachyonychia_congenit_1_1_1_3 hd_h_pc.T.international_pachyonychia_congenit_1_1_1_4 hd_h_pc.T.international_pachyonychia_congenit_1_1_1_5 hd_h_pc.T.international_pachyonychia_congenit_1_1_1_6 hd_h_pc.T.international_pachyonychia_congenit_1_1_1_7" colspan="8" scope="col" rowspan="1" style="text-align:left;vertical-align:middle;"><b>Plantar pain w/plantar keratoderma&#x000a0;<sup>2</sup></b></td></tr><tr><td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_1" colspan="2" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Often require medication for pain</td><td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">65 (24%)</td><td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">12 (18%)</td><td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">5 (26%)</td><td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">74 (31%)</td><td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_6" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">19 (18%)</td><td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_7" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">175 (25%)</td></tr><tr><td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_1" colspan="2" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Very painful, but do not use medication</td><td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">114 (43%)</td><td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">32 (47%)</td><td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">11 (58%)</td><td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">111 (46%)</td><td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_6" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">34 (33%)</td><td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_7" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">302 (43%)</td></tr><tr><td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_1" colspan="2" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Somewhat painful</td><td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">77 (29%)</td><td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">24 (35%)</td><td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">3 (16%)</td><td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">50 (21%)</td><td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_6" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">36 (35%)</td><td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_7" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">190 (27%)</td></tr><tr><td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_1" colspan="2" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;"><b>Total w/plantar keratoderma/pain</b></td><td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>256 (96%)</b></td><td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>68 (100%)</b></td><td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>19 (100%)</b></td><td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>235 (98%)</b></td><td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_6" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>89 (86%)</b></td><td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_7" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>667 (96%)</b></td></tr><tr><td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_1 hd_h_pc.T.international_pachyonychia_congenit_1_1_1_2 hd_h_pc.T.international_pachyonychia_congenit_1_1_1_3 hd_h_pc.T.international_pachyonychia_congenit_1_1_1_4 hd_h_pc.T.international_pachyonychia_congenit_1_1_1_5 hd_h_pc.T.international_pachyonychia_congenit_1_1_1_6 hd_h_pc.T.international_pachyonychia_congenit_1_1_1_7" colspan="8" scope="col" rowspan="1" style="text-align:left;vertical-align:middle;"><b>Palmar keratoderma</b></td></tr><tr><td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_1" colspan="2" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Always (never completely goes away)</td><td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">86 (28%)</td><td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">11 (15%)</td><td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">2 (09%)</td><td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">148 (60%)</td><td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_6" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">21 (16%)</td><td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_7" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">268 (35%)</td></tr><tr><td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_1" colspan="2" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Sometimes (hands clear up completely at times)</td><td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">32 (11%)</td><td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">7 (10%)</td><td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">1 (05%)</td><td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">15 (06%)</td><td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_6" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">22 (17%)</td><td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_7" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">77 (10%)</td></tr><tr><td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_1" colspan="2" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Seldom (hands usually clear of symptoms)</td><td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">49 (16%)</td><td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">13 (18%)</td><td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">3 (14%)</td><td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">22 (09%)</td><td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_6" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">27 (21%)</td><td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_7" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">114 (15%)</td></tr><tr><td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_1" colspan="2" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;"><b>Total w/palmar keratoderma</b></td><td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>167 (55%)</b></td><td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>31 (44%)</b></td><td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>6 (27%)</b></td><td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>185 (75%)</b></td><td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_6" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>70 (54%)</b></td><td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_7" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>459 (59%)</b></td></tr><tr><td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_1 hd_h_pc.T.international_pachyonychia_congenit_1_1_1_2 hd_h_pc.T.international_pachyonychia_congenit_1_1_1_3 hd_h_pc.T.international_pachyonychia_congenit_1_1_1_4 hd_h_pc.T.international_pachyonychia_congenit_1_1_1_5 hd_h_pc.T.international_pachyonychia_congenit_1_1_1_6 hd_h_pc.T.international_pachyonychia_congenit_1_1_1_7" colspan="8" scope="col" rowspan="1" style="text-align:left;vertical-align:middle;"><b>Additional findings</b></td></tr><tr><td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_1" colspan="2" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;"><b>Oral leukokeratosis</b></td><td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">269 (88%)</td><td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">18 (25%)</td><td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">4 (18%)</td><td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">88 (36%)</td><td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_6" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">34 (26%)</td><td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_7" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">413 (53%)</td></tr><tr><td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_1" colspan="2" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;"><b>Cysts</b></td><td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">188 (62%)</td><td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">49 (69%)</td><td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">4 (18%)</td><td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">64 (26%)</td><td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_6" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">121 (93%)</td><td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_7" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">426 (55%)</td></tr><tr><td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_1" colspan="2" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;"><b>Follicular hyperkeratosis</b></td><td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">162 (53%)</td><td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">30 (42%)</td><td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">0 (00%)</td><td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">30 (12%)</td><td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_6" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">86 (66%)</td><td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_7" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">308 (40%)</td></tr><tr><td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_1" colspan="2" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;"><b>Natal or prenatal teeth</b></td><td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">12 (04%)</td><td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">0 (00%)</td><td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">0 (00%)</td><td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">0 (00%)</td><td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_6" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">99 (76%)</td><td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_7" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">111 (14%)</td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt>1. </dt><dd><div id="pc.TF.2.1"><p class="no_margin">Data from 774 individuals enrolled in the International PC Research Registry with genetically confirmed pachyonychia congenita</p></div></dd><dt>2. </dt><dd><div id="pc.TF.2.2"><p class="no_margin">By age &#x02264;10 years</p></div></dd></dl></div></div></div><p><b>Hypertrophic nail dystrophy,</b> the predominant clinical feature of PC, is typically noted within the first few months to years of life, though in rare instances it presents later in life. The nail dystrophy appears to fall into two phenotypes:</p><ul><li class="half_rhythm"><div>Nails that grow to full length and have an upward slant caused by the prominent distal hyperkeratosis (often with an accentuated curvature of the nail)</div></li><li class="half_rhythm"><div>Nails that have a nail plate that terminates prematurely leaving a gently sloping distal region of hyperkeratosis and exposed distal finger tip</div></li></ul><p><b>Focal palmoplantar keratoderma</b> usually presents during the first few years of life when a child starts bearing weight and walking. Blisters develop beneath the keratoderma resulting in intense pain. For many individuals, the blisters and constant foot pain are more severe in warmer weather than cooler weather. The pain associated with plantar focal blistering may require the use of crutches, canes, or wheelchairs. Rarely, keratosis palmoplantaris transgrediens (the contiguous extension of hyperkeratosis beyond the palmar and/or plantar skin) is present.</p><ul><li class="half_rhythm"><div>Focal non-epidermolytic palmoplantar keratoderma (FNEPPK), defined as keratoderma of varying severity that may occur on the palms and soles with no (or very mild) nail dystrophy, was previously thought to be a distinct entity but is now considered part of the spectrum of PC.</div></li></ul><p><b>Oral leukokeratosis</b> (thickened white patches on the tongue and cheek) is often present. In babies, oral leukokeratosis can be misdiagnosed as <i>Candida albicans</i> and may cause difficulty in sucking.</p><p><b>Follicular keratosis,</b> usually on the elbows, knees or trunk, occurs in some persons. It is more prevalent in late childhood and teenage years and becomes less problematic in adults.</p><p><b>Pilosebaceous cysts including widespread steatocystomas/steatocysts (benign lesions) and vellus hair cysts.</b> Cysts may increase in number at puberty. Early onset has been reported [<a class="bk_pop" href="#pc.REF.feng.2003.452">Feng et al 2003</a>] and is recorded in the <a href="http://www.pachyonychia.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">International Pachyonychia Congenita Research Registry</a> (IPCRR).</p><ul><li class="half_rhythm"><div>Steatocystoma multiplex (SM), defined as widespread steatocystomas that can develop at puberty with subtle nail involvement but no palmoplantar keratoderma, occurs in association with <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> pathogenic variants in <i>KRT17</i> (see <a class="figpopup" href="/books/NBK1280/table/pc.T.molecular_genetic_testing_used_in_p/?report=objectonly" target="object" rid-figpopup="figpcTmoleculargenetictestingusedinp" rid-ob="figobpcTmoleculargenetictestingusedinp">Table 1</a>, footnote 8).</div></li></ul><p><b>Natal teeth or prenatal teeth.</b> Although some individuals have a few prenatal or natal teeth, this finding is not consistently present even within the same family [<a class="bk_pop" href="#pc.REF.leachman.2005.3">Leachman et al 2005</a>]. Natal teeth are usually associated with pathogenic variants in <i>KRT17</i>. Primary and secondary dentition is normal.</p><p><b>Other findings</b> that may occur:</p><ul><li class="half_rhythm"><div>Excessive sweating of the palms and soles (palmoplantar hyperhydrosis), observed in approximately 50% of individuals</div></li><li class="half_rhythm"><div>Axillary and inguinal cyst formation</div></li><li class="half_rhythm"><div>Excessive production of waxy material in the ear</div></li><li class="half_rhythm"><div>Severe and unexplained ear pain</div></li><li class="half_rhythm"><div>Hoarseness (laryngeal involvement), reported primarily in young children. Although rare, laryngeal involvement may cause life-threatening respiratory distress requiring intervention.</div></li><li class="half_rhythm"><div>Angular cheilitis (inflammation and fissuring at the angles of the mouth) which is sometimes secondarily infected</div></li><li class="half_rhythm"><div>Paronychia with pronounced edema (and occasional blister formation) under the nails; may exhibit lymphatic extension and may sometimes be caused by infection</div></li></ul></div><div id="pc.Phenotype_Correlations_by_Gene"><h3>Phenotype Correlations by Gene</h3><p>Leukokeratosis with laryngeal involvement may be seen in infants and children with PC-K6a (see <a href="#pc.Nomenclature">Nomenclature</a>) caused by a <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in <i>KRT6A</i>.</p><p>All cases of "failure to thrive" and poor feeding in infancy have been found to be in individuals with PC-K6a, caused by a <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in <i>KRT6A</i>.</p><p>Focal non-epidermolytic palmoplantar keratoderma (FNEPPK) has been described only in individuals who have a <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in either <i>KRT6C</i> or <i>KRT16</i> [<a class="bk_pop" href="#pc.REF.wilson.2010.425">Wilson et al 2010</a>, <a class="bk_pop" href="#pc.REF.fu.2011.1025">Fu et al 2011</a>].</p><p>Steatocystoma multiplex (SM) has been reported only in individuals who have a <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in <i>KRT17</i> [<a class="bk_pop" href="#pc.REF.covello.1998.475">Covello et al 1998</a>].</p><p>Individuals with a history of natal teeth are more likely to have a <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in <i>KRT17</i> (see <a class="figpopup" href="/books/NBK1280/table/pc.T.international_pachyonychia_congenit/?report=objectonly" target="object" rid-figpopup="figpcTinternationalpachyonychiacongenit" rid-ob="figobpcTinternationalpachyonychiacongenit">Table 2</a>).</p></div><div id="pc.GenotypePhenotype_Correlations"><h3>Genotype-Phenotype Correlations</h3><p>Based on data on 774 individuals with PC in the IPCRR, clear <a class="def" href="/books/n/gene/glossary/def-item/genotype-phenotype-correlations/">genotype-phenotype correlations</a> are evident [<a class="bk_pop" href="#pc.REF.fu.2011.1025">Fu et al 2011</a>, <a class="bk_pop" href="#pc.REF.spaunhurst.2012.875">Spaunhurst et al 2012</a>] (see <a class="figpopup" href="/books/NBK1280/table/pc.T.international_pachyonychia_congenit/?report=objectonly" target="object" rid-figpopup="figpcTinternationalpachyonychiacongenit" rid-ob="figobpcTinternationalpachyonychiacongenit">Table 2</a>).</p><p>In the following instances, the <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> may vary among individuals with the same <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>:</p><ul><li class="half_rhythm"><div>The same <i>KRT17</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in the highly conserved helix initiation motif has been observed in classic PC and in a few individuals with the milder variant SM with few or no nail changes. The modifying factors responsible for this <a class="def" href="/books/n/gene/glossary/def-item/variable-expressivity/">variable expressivity</a> are not known.</div></li><li class="half_rhythm"><div>In a few reports of late-onset PC, pathogenic variants have been identified outside the helix boundary and some have questioned whether the location of the <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> affects the age at onset. However, the ages in these cases are the expected ages at onset for the particular type of PC and should likely not be referred to as "late-onset."</div></li></ul></div><div id="pc.Nomenclature"><h3>Nomenclature</h3><p>Based on data from the International Pachyonychia Congenita Research Registry (IPCRR), the most recent classification for pachyonychia congenita is by mutated <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> [<a class="bk_pop" href="#pc.REF.mclean.2011.1015">McLean et al 2011</a>, <a class="bk_pop" href="#pc.REF.wilson.2011.1018">Wilson et al 2011</a>]:</p><ul><li class="half_rhythm"><div>PC-K6a (caused by pathogenic variants in <i>KRT6A</i>)</div></li><li class="half_rhythm"><div>PC-K6b (caused by pathogenic variants in <i>KRT6B</i>)</div></li><li class="half_rhythm"><div>PC-K6c (caused by pathogenic variants in <i>KRT6C</i>)</div></li><li class="half_rhythm"><div>PC-K16 (caused by pathogenic variants in <i>KRT16</i>)</div></li><li class="half_rhythm"><div>PC-K17 (caused by pathogenic variants in <i>KRT17</i>)</div></li></ul><p>The classification suggested for PC prior to the identification of the genetic basis of the disease was based solely on clinical findings. Historically, the two major subtypes of PC were based on subtle variable phenotypic features (primarily on the presence or absence of pilosebaceous cysts and natal or prenatal teeth) [<a class="bk_pop" href="#pc.REF.leachman.2005.3">Leachman et al 2005</a>, <a class="bk_pop" href="#pc.REF.liao.2007.199">Liao et al 2007</a>]:</p><ul><li class="half_rhythm"><div>PC-1 (Jadassohn-Lewandowski syndrome)</div></li><li class="half_rhythm"><div>PC-2 (Jackson-Lawler syndrome)</div></li></ul><p>With detailed clinical histories and pathogenic variants identified in an increasing number of people with PC, it became clear that the older classification of PC-1 and PC-2 was not applicable to the broader population of individuals with PC.</p></div><div id="pc.Prevalence"><h3>Prevalence</h3><p>The rarity of PC makes it difficult to accurately assess its prevalence.</p><p>The <a href="http://www.pachyonychia.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">International PC Research Registry</a> has identified 774 individuals in 419 families with genetically confirmed PC.</p></div></div><div id="pc.Genetically_Related_Allelic_Disorders"><h2 id="_pc_Genetically_Related_Allelic_Disorders_">Genetically Related (Allelic) Disorders</h2><p><b><i>KRT6A</i>, <i>KRT6B</i>, <i>KRT6C</i>, <i>KRT16</i>, <i>KRT17</i>.</b> No phenotypes other than those discussed in this <i>GeneReview</i> are known to be associated with pathogenic variants in these genes.</p></div><div id="pc.Differential_Diagnosis"><h2 id="_pc_Differential_Diagnosis_">Differential Diagnosis</h2><p><b>Onychomycosis.</b> While the hyperkeratotic nail thickening seen in pachyonychia congenita (PC) may be mistaken for onychomycosis, dermatophytic infections do not affect all finger and toenails, particularly at an early age. In the rare conditions of autoimmune endocrinopathy-candidiasis-ectodermal dystrophy (APECED) and systemic mucocutaneous candidosis, all nails may be <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a>.</p><p><b>Oral leukokeratosis</b> together with nail dystrophy is often an indication of pachyonychia congenita and may be mistaken for <i>Candida albicans</i> (thrush), white sponge nevus, and/or leukoplakia.</p><p><a href="/books/n/gene/ebs/"><b>Epidermolysis bullosa simplex</b></a>
<b>(EBS)</b> or other palmoplantar keratodermas can result in a similar pattern of plantar blister formation or hyperkeratosis, respectively; however, they do not share the characteristic nail changes of PC.</p><p>Note: EBS may be incorrectly diagnosed in young children with PC because they have a greater tendency toward blister formation and lesser tendency toward keratoderma.</p><p><a href="/books/n/gene/ed2/"><b>Clouston syndrome</b></a> (hidrotic ectodermal dysplasia 2), an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> disorder caused by a <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in <i>GJB6</i>, the <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> encoding the gap junction beta-6 protein, can also mimic PC [<a class="bk_pop" href="#pc.REF.hale.2015.1447">Hale et al 2015</a>]. Alopecia does not typically occur in PC, whereas variable alopecia is a relatively common feature of Clouston syndrome.</p><p><b>Nonsyndromic <a class="def" href="/books/n/gene/glossary/def-item/congenital/">congenital</a> nail disorder 10</b> (OMIM <a href="http://omim.org/entry/614157" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">614157</a>) without the associated palmoplantar keratoderma or other features of PC can be confused with PC. This is an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> disorder caused by <a class="def" href="/books/n/gene/glossary/def-item/biallelic/">biallelic</a> pathogenic variants in <i>FZD6</i>, encoding frizzled-6 [<a class="bk_pop" href="#pc.REF.wilson.2013.58">Wilson et al 2013</a>, <a class="bk_pop" href="#pc.REF.kasparis.2016.884">Kasparis et al 2016</a>].</p><p><b>Familial onychogryphosis</b> without the associated palmoplantar keratoderma or other features of PC can be confused with PC. Individuals who have nail findings only are unlikely to have a <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in one of the PC-related genes.</p><p><b>Twenty-nail dystrophy</b> (OMIM <a href="http://omim.org/entry/161050" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">161050</a>) may occur without keratoderma or other associated changes. Autosomal dominant inheritance has been described.</p><p><a href="/books/n/gene/dkc/"><b>Dyskeratosis congenita</b></a>
<b>(DC)</b> manifests with features overlapping with PC including nail dystrophy, palmoplantar keratoderma (PPK), hyperhidrosis, and oral leukoplakia. Distinctive features include reticulate hyperpigmentation, skin tumors, and hematologic manifestation. To date, pathogenic variants in <i>ACD</i>, <i>CTC1</i>, <i>DKC1</i>, <i>NHP2</i>, <i>NOP10</i>, <i>PARN</i>, <i>RTEL1</i>, <i>TERC</i>, <i>TERT</i>, <i>TINF2</i>, and <i>WRAP53</i> have been shown to cause DC; <a class="def" href="/books/n/gene/glossary/def-item/mode-of-inheritance/">mode of inheritance</a> varies by <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>.</p><p><b>Palmoplantar keratoderma striata (PPKS1)</b> (OMIM <a href="http://omim.org/entry/148700" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">148700</a>), an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> disorder caused by a <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in <i>DSG1</i>, can be confused with focal non-epidermolytic palmoplantar keratoderma (FNEPPK) / pachyonychia congenita [<a class="bk_pop" href="#pc.REF.lovgren.2017.1345">Lovgren et al 2017</a>]. However, pain is typically either absent or less significant in PPKS1 than in FNEPPK or PC.</p><p><b>Punctate PPK type 1</b> (OMIM <a href="http://omim.org/entry/148600" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">148600</a>), an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> disorder caused by a <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in <i>AAGAB</i>, can be painful and focal (due to coalescence of lesions) [<a class="bk_pop" href="#pc.REF.pohler.2012.1272">Pohler et al 2012</a>].</p><p><b>Olmsted syndrome</b> (OMIM <a href="http://omim.org/entry/614594" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">614594</a>) is characterized by painful palmoplantar keratoderma that may occur with additional features including periorificial keratotic plaques and sometimes constricting digital bands on hands and feet that result in spontaneous amputation, mutilating PPK, alopecia, nail dystrophy, and itching of lesions. Olmsted syndrome is caused by a <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in <i>TRPV3</i> [<a class="bk_pop" href="#pc.REF.lin.2012.558">Lin et al 2012</a>; <a class="bk_pop" href="#pc.REF.wilson.2015.2879">Wilson et al 2015</a>] and normally inherited in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> manner, although recessive inheritance has been reported [<a class="bk_pop" href="#pc.REF.duchatelet.2014.675">Duchatelet et al 2014</a>].</p></div><div id="pc.Management"><h2 id="_pc_Management_">Management</h2><div id="pc.Evaluations_Following_Initial_Diagnos"><h3>Evaluations Following Initial Diagnosis</h3><p>To establish the extent of disease and needs in an individual diagnosed with pachyonychia congenita, the following evaluations are recommended:</p><ul><li class="half_rhythm"><div>Thorough clinical examination to assess each affected area. These will vary based on the specific <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> involved (see <a class="figpopup" href="/books/NBK1280/table/pc.T.international_pachyonychia_congenit/?report=objectonly" target="object" rid-figpopup="figpcTinternationalpachyonychiacongenit" rid-ob="figobpcTinternationalpachyonychiacongenit">Table 2</a>) and may need to be repeated once genetic testing is completed in order to fully understand the <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> of the <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual.</div></li><li class="half_rhythm"><div>Consultation with a clinical geneticist and/or genetic counselor</div></li></ul></div><div id="pc.Treatment_of_Manifestations"><h3>Treatment of Manifestations</h3><p>Preliminary treatment guidelines have been published [<a class="bk_pop" href="#pc.REF.goldberg.2014.279">Goldberg et al 2014</a>] (<a href="http://onlinelibrary.wiley.com/doi/10.1111/jdv.12098/full" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">full text</a>) and continue to be refined.</p><p>The current treatment modalities primarily center on symptomatic relief of pain, hygienic grooming practices including paring of hyperkeratotic areas, treatment of secondary infection when indicated, and use of various walking aids including wheelchairs, crutches, and canes.</p><p><b>Palmoplantar keratoderma.</b> Frequent grooming of the feet is essential and includes paring down the hyperkeratotic areas. However, trimming too aggressively can greatly increase pain. Some find it helpful to soak the feet prior to the paring. The surface of the skin and the instruments used should be clean to avoid infection. Blisters should be punctured with a sterile needle, the fluid drained, and the blister roof left in place until it dries and is shed away.</p><p>Topical therapies to remove the hyperkeratosis:</p><ul><li class="half_rhythm"><div><b>Emollients</b> such as Vaseline<sup>&#x000ae;</sup> or lanolin-containing products are frequently used. Note: Creams and lotions containing keratolyics such as urea, lactic acid, salicylic acid, or propylene glycol have little effect, with some reporting negative side effects. Occlusive ointments are often poorly tolerated.</div></li><li class="half_rhythm"><div><b>Oral retinoids,</b> while reducing the keratoderma, do not affect the underlying blistering and fragility of the skin and sometimes increase the pain. Careful regulation of the dosage is necessary [<a class="bk_pop" href="#pc.REF.gruber.2012.e193">Gruber et al 2012</a>].</div></li></ul><p>Special orthotics or insoles, wicking socks, ventilated footwear or cushioned footwear can help to lessen the pain although pain varies from day to day and at times can be intense even at rest.</p><p>Maintaining ideal body weight can be a factor in reducing the hyperkeratosis and pain. Limiting walking or standing can help to reduce trauma and slightly diminish the resulting blisters, callus, and pain.</p><p>The origin, nature, and underlying mechanism of plantar pain in individuals with PC is poorly understood. Several recent studies suggest that neuropathic pain treatments may be useful in individuals with PC who experience plantar pain [<a class="bk_pop" href="#pc.REF.pan.2016.2843">Pan et al 2016</a>; <a class="bk_pop" href="#pc.REF.wallis.2016.26">Wallis et al 2016</a>; Authors, unpublished] (see <a href="#pc.Therapies_Under_Investigation">Therapies Under Investigation</a>).</p><p><b>Nail dystrophy.</b> Thickened nails are not typically painful, but become so when infected or traumatized. An effective tool for very thick nails and for children is a guillotine-type pet nail clipper which places no pressure on the nails. Other tools frequently used are razor or surgical blades or sanders such as a Dremel<sup>&#x000ae;</sup> tool.</p><p>If bacterial or fungal infections occur, systemic antibiotics or antifungals are indicated.</p><p>Particularly troublesome nails can be successfully removed surgically; however, few <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals have had this procedure and in many cases &#x02013; regardless of the specific <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> &#x02013; the nails have regrown [<a class="bk_pop" href="#pc.REF.deklotz.2017.990">DeKlotz et al 2017</a>].</p><p><b>Oral leukokeratosis.</b> Good oral hygiene and frequent gentle brushing with a toothbrush can significantly improve the appearance of the thick, white patches on the tongue and oral mucosa; however, if done too vigorously, brushing may also traumatize the mucosa resulting in reactive hyperkeratosis.</p><p>Some individuals have reported reduction of the leukokeratosis in response to oral antibiotics, suggesting a possible bacterial contribution; more likely, improvement may be a response to the anti-inflammatory properties of the antibiotics.</p><p><b>Follicular hyperkeratosis.</b> Especially bothersome for children and teens, this finding can be treated with alpha-hydroxy acid creams or lotions or keratolytic emollients; however, these treatments may not be especially effective for PC. The use of emollients such as Vaseline<sup>&#x000ae;</sup> or lanolin-containing products is reported to be as effective.</p><p><b>Leukokeratosis with laryngeal involvement.</b> Reported only in children with PC-K6a, respiratory insufficiency can on occasion become life threatening, requiring emergent surgical intervention to reestablish the airway. The surgical procedures are repeated as necessary to maintain an open airway; however, surgical procedures to the larynx aimed at improving hoarseness should be avoided as they may tend to worsen the condition.</p><p><b>Cysts.</b> Steatocystoma multiplex and other pilosebaceous cysts can be treated by incision with a number 11 blade and subsequent expression of the contents of the cyst ("incision and drainage"). Oral antibiotics may be indicated in the case of secondary infection. A culture should be obtained if infection is a consideration. Intralesional injection of steroid (e.g., triamcinolone) may reduce inflammation of the area if infection is not suspected. If necessary, cysts can be excised.</p><p><b>Failure to thrive.</b> Poor feeding in infancy has been reported to be ameliorated by the use of a soft nipple with an enlarged opening to reduce the sucking required.</p></div><div id="pc.Prevention_of_Secondary_Complications"><h3>Prevention of Secondary Complications</h3><p>Infection of the skin and nails following grooming or trauma is the most common secondary complication seen in PC.</p><ul><li class="half_rhythm"><div>Pre- and post-grooming hygiene and use of clean instruments minimizes this complication.</div></li><li class="half_rhythm"><div>Antibiotics may be indicated when infection occurs.</div></li><li class="half_rhythm"><div>A simple "bleach bath" regimen using a mild bleach solution can help prevent infections.</div></li></ul></div><div id="pc.Surveillance"><h3>Surveillance</h3><p>In general, individuals with PC have no known associated systemic diseases or predispositions that require routine surveillance.</p></div><div id="pc.AgentsCircumstances_to_Avoid"><h3>Agents/Circumstances to Avoid</h3><p>Some report that higher temperatures and higher humidity worsen the condition.</p></div><div id="pc.Evaluation_of_Relatives_at_Risk"><h3>Evaluation of Relatives at Risk</h3><p>Molecular genetic testing of at-risk relatives in a family with PC is not indicated because the <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> is readily observed from a young age and no interventions can prevent the development of manifestations or reduce their severity.</p><p>See <a href="#pc.Related_Genetic_Counseling_Issues">Genetic Counseling</a> for issues related to testing of at-risk relatives for <a class="def" href="/books/n/gene/glossary/def-item/genetic-counseling/">genetic counseling</a> purposes.</p></div><div id="pc.Pregnancy_Management"><h3>Pregnancy Management</h3><p>For a pregnant woman with PC, weight gain (increasing stress on the plantar surface) or altered hormonal environment during pregnancy may worsen the painful plantar keratoderma.</p></div><div id="pc.Therapies_Under_Investigation"><h3>Therapies Under Investigation</h3><p>In 2014, a Phase 1b clinical trial sponsored by PC Project and TransDerm was performed using topical sirolimus. This study included 15 <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals and was conducted by Dr Joyce Teng at Stanford University. Background research for this trial was previously published [<a class="bk_pop" href="#pc.REF.hickerson.2009.82">Hickerson et al 2009</a>].</p><p>Short interfering RNA (siRNA) can selectively block expression of a specific K6a-causing <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> [<a class="bk_pop" href="#pc.REF.hickerson.2008.594">Hickerson et al 2008</a>, <a class="bk_pop" href="#pc.REF.leachman.2008.151">Leachman et al 2008</a>]. The siRNA trial included treatment of a single individual with a specific <i>KRT6A</i> pathogenic variant in a dose-escalation trial of an siRNA directed against the p.Asn171Lys mutated <a class="def" href="/books/n/gene/glossary/def-item/allele/">allele</a> [<a class="bk_pop" href="#pc.REF.leachman.2010.442">Leachman et al 2010</a>]. The <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual did not experience any adverse effects from the experimental treatment. The affected person also experienced callus regression on the foot treated with siRNA.</p><p>Botulinum toxin has been used to treat pain in several <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals, with promising results [<a class="bk_pop" href="#pc.REF.swartling.2006.763">Swartling &#x00026; Vahlquist 2006</a>, <a class="bk_pop" href="#pc.REF.swartling.2010.1072">Swartling et al 2010</a>, <a class="bk_pop" href="#pc.REF.gonz_lezramos.2016.32">Gonz&#x000e1;lez-Ramos et al 2016</a>]. In addition to these published investigations, a number of other individuals have been treated with botulinum toxin.</p><p>Several persons have been treated with statins. The results from studies are mixed. Further research is being conducted and additional animal testing is proposed [<a class="bk_pop" href="#pc.REF.zhao.2011.1045">Zhao et al 2011</a>].</p><p>Other therapies currently under investigation include anti-TNF biologics, duloxetine or duloxetine and a tricyclic combination, gabapentin, topical gabapentin, and capsaicin injections.</p><p>Search <a href="http://clinicaltrials.gov/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">ClinicalTrials.gov</a> in the US and <a href="http://www.clinicaltrialsregister.eu/ctr-search/search" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">EU Clinical Trials Register</a> in Europe for access to information on clinical studies for a wide range of diseases and conditions.</p></div></div><div id="pc.Genetic_Counseling"><h2 id="_pc_Genetic_Counseling_">Genetic Counseling</h2><p>
<i>Genetic counseling is the process of providing individuals and families with
information on the nature, inheritance, and implications of genetic disorders to help them
make informed medical and personal decisions. The following section deals with genetic
risk assessment and the use of family history and genetic testing to clarify genetic
status for family members. This section is not meant to address all personal, cultural, or
ethical issues that individuals may face or to substitute for consultation with a genetics
professional</i>. &#x02014;ED.</p><div id="pc.Mode_of_Inheritance"><h3>Mode of Inheritance</h3><p>Pachyonychia congenita (PC) is inherited in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> manner.</p></div><div id="pc.Risk_to_Family_Members"><h3>Risk to Family Members</h3><p><b>Parents of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div>Up to 70% of individuals diagnosed with pachyonychia congenita have an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> parent.</div></li><li class="half_rhythm"><div>A <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> with pachyonychia congenita may have the disorder as the result of a <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>. The proportion of cases caused by a <i>de novo</i> pathogenic variant is approximately 30%. Of these, some may be novel pathogenic variants while others may be recurrent pathogenic variants identified in other families.</div></li><li class="half_rhythm"><div>Complete clinical examination by a dermatologist to confirm the absence of <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> is recommended for the evaluation of parents of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> with an apparent <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>; if there are no phenotypic signs, no parental genetic testing is necessary.</div></li></ul><p><b>Sibs of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>.</b> The risk to the sibs of a proband depends on the genetic status of the proband's parents:</p><ul><li class="half_rhythm"><div class="half_rhythm">If a parent of the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> is <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a>, the risk to the sibs is 50%.</div></li><li class="half_rhythm"><div class="half_rhythm">If the parents are clinically unaffected, the risk to the sibs of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> is low, but slightly greater than that of the general population because of the possibility of <a class="def" href="/books/n/gene/glossary/def-item/germline-mosaicism/">germline mosaicism</a>.</div><div class="half_rhythm">The incidence of <a class="def" href="/books/n/gene/glossary/def-item/germline-mosaicism/">germline mosaicism</a> is not known. It is extremely rare: of 774 cases, a single case of germline mosaicism (0.13%) has been reported for PC [<a class="bk_pop" href="#pc.REF.pho.2011.1077">Pho et al 2011</a>].</div></li></ul><p><b>Offspring of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>.</b> Each child of an individual with pachyonychia congenita has a 50% chance of inheriting the <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>.</p><p><b>Other family members.</b> The risk to other family members depends on the status of the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>'s parents: if a parent is <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a>, his or her family members may be affected and at risk of having affected children.</p></div><div id="pc.Related_Genetic_Counseling_Issues"><h3>Related Genetic Counseling Issues</h3><p>Because PC is a very rare disorder, <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals and families often feel completely isolated. Connecting affected individuals and families to the PC patient advocacy group (see <a href="#pc.Resources">Resources</a>), which offers many different support services, can often be extremely valuable [<a class="bk_pop" href="#pc.REF.schwartz.2013.42">Schwartz et al 2013</a>].</p><p><b>Considerations in families with an apparent <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>.</b> When neither parent of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> with an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> condition has the pathogenic variant identified in the proband or clinical evidence of the disorder, the pathogenic variant is likely <i>de novo</i>. However, non-medical explanations including <a class="def" href="/books/n/gene/glossary/def-item/alternate-paternity/">alternate paternity</a> or maternity (e.g., with assisted reproduction) and undisclosed adoption could also be explored.</p><p><b>Family planning</b></p><ul><li class="half_rhythm"><div>The optimal time for determination of genetic risk and discussion of the availability of prenatal testing is before pregnancy.</div></li><li class="half_rhythm"><div>It is appropriate to offer <a class="def" href="/books/n/gene/glossary/def-item/genetic-counseling/">genetic counseling</a> (including discussion of potential risks to offspring and reproductive options) to young adults who are <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> or at risk.</div></li></ul><p><b>DNA banking</b> is the storage of DNA (typically extracted from white blood cells) for possible future use. Because it is likely that testing methodology and our understanding of genes, allelic variants, and diseases will improve in the future, consideration should be given to banking DNA of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals.</p></div><div id="pc.Prenatal_Testing_and_Preimplantation"><h3>Prenatal Testing and Preimplantation Genetic Diagnosis</h3><p>Once the <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> has been identified in an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> family member, prenatal testing for a pregnancy at increased risk and <a class="def" href="/books/n/gene/glossary/def-item/preimplantation-genetic-diagnosis/">preimplantation genetic diagnosis</a> are possible.</p></div></div><div id="pc.Resources"><h2 id="_pc_Resources_">Resources</h2><p>
<i>GeneReviews staff has selected the following disease-specific and/or umbrella
support organizations and/or registries for the benefit of individuals with this disorder
and their families. GeneReviews is not responsible for the information provided by other
organizations. For information on selection criteria, click <a href="/books/n/gene/app4/">here</a>.</i></p><ul><li class="half_rhythm"><div><b>Pachyonychia Congenita Project and International Pachyonychia Congenita Research Registry (IPCRR)</b></div><div>PC Project</div><div>P.O. Box 17850</div><div>Holladay UT 84117</div><div><b>Phone:</b> 801-987-8758</div><div><b>Email:</b> info@pachyonychia.org</div><div><a href="http://www.pachyonychia.org" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.pachyonychia.org</a></div></li><li class="half_rhythm"><div><b>National Institute of Arthritis and Musculoskeletal and Skin Diseases</b></div><div><a href="http://www.niams.nih.gov/Health_Info/pachyonychia_congenita/default.asp" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Pachyonychia Congenita</a></div></li></ul></div><div id="pc.Molecular_Genetics"><h2 id="_pc_Molecular_Genetics_">Molecular Genetics</h2><p><i>Information in the Molecular Genetics and OMIM tables may differ from that elsewhere in the GeneReview: tables may contain more recent information. &#x02014;</i>ED.</p><div id="pc.molgen.TA" class="table"><h3><span class="label">Table A.</span></h3><div class="caption"><p>Pachyonychia Congenita: Genes and Databases</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1280/table/pc.molgen.TA/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__pc.molgen.TA_lrgtbl__"><table class="no_bottom_margin"><tbody><tr><th id="hd_b_pc.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;">Gene</th><th id="hd_b_pc.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;">Chromosome Locus</th><th id="hd_b_pc.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;">Protein</th><th id="hd_b_pc.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;">Locus-Specific Databases</th><th id="hd_b_pc.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;">HGMD</th><th id="hd_b_pc.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;">ClinVar</th></tr><tr><td headers="hd_b_pc.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;"><a href="/gene/3853" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=gene"><i>KRT6A</i></a></td><td headers="hd_b_pc.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/genome/gdv/?context=gene&#x00026;acc=3853" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">12q13<wbr style="display:inline-block"></wbr>​.13</a></td><td headers="hd_b_pc.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.uniprot.org/uniprot/P02538" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Keratin, type II cytoskeletal 6A</a></td><td headers="hd_b_pc.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.interfil.org/details.php?id=NM_005554" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Human Intermediate Filament Database KRT6A</a><br /><a href="http://databases.lovd.nl/shared/genes/KRT6A" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">KRT6A database</a></td><td headers="hd_b_pc.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.hgmd.cf.ac.uk/ac/gene.php?gene=KRT6A" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">KRT6A</a></td><td headers="hd_b_pc.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/clinvar/?term=KRT6A[gene]" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">KRT6A</a></td></tr><tr><td headers="hd_b_pc.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;"><a href="/gene/3854" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=gene"><i>KRT6B</i></a></td><td headers="hd_b_pc.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/genome/gdv/?context=gene&#x00026;acc=3854" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">12q13<wbr style="display:inline-block"></wbr>​.13</a></td><td headers="hd_b_pc.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.uniprot.org/uniprot/P04259" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Keratin, type II cytoskeletal 6B</a></td><td headers="hd_b_pc.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.interfil.org/details.php?id=NM_005555" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Human Intermediate Filament Database KRT6B</a><br /><a href="http://databases.lovd.nl/shared/genes/KRT6B" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">KRT6B database</a></td><td headers="hd_b_pc.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.hgmd.cf.ac.uk/ac/gene.php?gene=KRT6B" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">KRT6B</a></td><td headers="hd_b_pc.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/clinvar/?term=KRT6B[gene]" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">KRT6B</a></td></tr><tr><td headers="hd_b_pc.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;"><a href="/gene/286887" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=gene"><i>KRT6C</i></a></td><td headers="hd_b_pc.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/genome/gdv/?context=gene&#x00026;acc=286887" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">12q13<wbr style="display:inline-block"></wbr>​.13</a></td><td headers="hd_b_pc.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.uniprot.org/uniprot/P48668" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Keratin, type II cytoskeletal 6C</a></td><td headers="hd_b_pc.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.interfil.org/details.php?id=NM_173086" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Human Intermediate Filament Database KRT6C</a></td><td headers="hd_b_pc.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.hgmd.cf.ac.uk/ac/gene.php?gene=KRT6C" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">KRT6C</a></td><td headers="hd_b_pc.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/clinvar/?term=KRT6C[gene]" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">KRT6C</a></td></tr><tr><td headers="hd_b_pc.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;"><a href="/gene/3868" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=gene"><i>KRT16</i></a></td><td headers="hd_b_pc.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/genome/gdv/?context=gene&#x00026;acc=3868" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">17q21<wbr style="display:inline-block"></wbr>​.2</a></td><td headers="hd_b_pc.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.uniprot.org/uniprot/P08779" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Keratin, type I cytoskeletal 16</a></td><td headers="hd_b_pc.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.interfil.org/details.php?id=NM_005557" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Human Intermediate Filament Database KRT16</a><br /><a href="http://databases.lovd.nl/shared/genes/KRT16" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">KRT16 database</a></td><td headers="hd_b_pc.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.hgmd.cf.ac.uk/ac/gene.php?gene=KRT16" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">KRT16</a></td><td headers="hd_b_pc.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/clinvar/?term=KRT16[gene]" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">KRT16</a></td></tr><tr><td headers="hd_b_pc.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;"><a href="/gene/3872" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=gene"><i>KRT17</i></a></td><td headers="hd_b_pc.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/genome/gdv/?context=gene&#x00026;acc=3872" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">17q21<wbr style="display:inline-block"></wbr>​.2</a></td><td headers="hd_b_pc.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.uniprot.org/uniprot/Q04695" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Keratin, type I cytoskeletal 17</a></td><td headers="hd_b_pc.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.interfil.org/details.php?id=NM_000422" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Human Intermediate Filament Database KRT17</a><br /><a href="http://databases.lovd.nl/shared/genes/KRT17" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">KRT17 database</a></td><td headers="hd_b_pc.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.hgmd.cf.ac.uk/ac/gene.php?gene=KRT17" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">KRT17</a></td><td headers="hd_b_pc.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/clinvar/?term=KRT17[gene]" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">KRT17</a></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div id="pc.TFA.1"><p class="no_margin">Data are compiled from the following standard references: <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> from
<a href="http://www.genenames.org/index.html" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">HGNC</a>;
<a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a> from
<a href="http://www.omim.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">OMIM</a>;
protein from <a href="http://www.uniprot.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">UniProt</a>.
For a description of databases (Locus Specific, HGMD, ClinVar) to which links are provided, click
<a href="/books/n/gene/app1/">here</a>.</p></div></dd></dl></div></div></div><div id="pc.molgen.TB" class="table"><h3><span class="label">Table B.</span></h3><div class="caption"><p>OMIM Entries for Pachyonychia Congenita (<a href="/omim/148041,148042,148067,148069,167200,167210,612315,615726,615728,615735" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">View All in OMIM</a>) </p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1280/table/pc.molgen.TB/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__pc.molgen.TB_lrgtbl__"><table><tbody><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/148041" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">148041</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">KERATIN 6A, TYPE II; KRT6A</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/148042" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">148042</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">KERATIN 6B, TYPE II; KRT6B</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/148067" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">148067</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">KERATIN 16, TYPE I; KRT16</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/148069" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">148069</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">KERATIN 17, TYPE I; KRT17</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/167200" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">167200</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">PACHYONYCHIA CONGENITA 1; PC1</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/167210" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">167210</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">PACHYONYCHIA CONGENITA 2; PC2</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/612315" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">612315</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">KERATIN 6C, TYPE II; KRT6C</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/615726" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">615726</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">PACHYONYCHIA CONGENITA 3; PC3</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/615728" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">615728</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">PACHYONYCHIA CONGENITA 4; PC4</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/615735" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">615735</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">PALMOPLANTAR KERATODERMA, NONEPIDERMOLYTIC, FOCAL OR DIFFUSE; PPKNEFD</td></tr></tbody></table></div></div><div id="pc.Molecular_Pathogenesi"><h3>Molecular Pathogenesi</h3><p>Keratins form a cytoskeletal intermediate filament network within all epithelial cells. Epithelia in different body regions utilize a range of different keratins. Keratins associated with PC are constitutively expressed in the nail, palmoplantar skin, oral mucosa, and hair. Thus, pathogenic variants in the genes encoding these keratins lead to pathology in these major body sites.</p><p>Pathogenic variants in at least 400 families have been reported to date [<a href="http://www.interfil.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri"><u>Human Intermediate Filament Database</u></a>, <a class="bk_pop" href="#pc.REF.szeverenyi.2008.351">Szeverenyi et al 2008</a>, <a class="bk_pop" href="#pc.REF.wilson.2011.1018">Wilson et al 2011</a>, <a class="bk_pop" href="#pc.REF.wilson.2014.343">Wilson et al 2014</a>, <a href="http://www.pachyonychia.org" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">IPCRR</a>]. A number of the pathogenic variants are recurrent but others are family specific. More than 100 different pathogenic variants have been identified. The majority are found in or near the helix initiation motif in the 1A <a class="def" href="/books/n/gene/glossary/def-item/domain/">domain</a> or the helix termination motif at the end of the 2B domain (<a class="figpopup" href="/books/NBK1280/figure/pc.F2/?report=objectonly" target="object" rid-figpopup="figpcF2" rid-ob="figobpcF2">Figure 2</a>), consistent with the location of pathogenic variants in most other keratin disorders [<a class="bk_pop" href="#pc.REF.wilson.2011.1018">Wilson et al 2011</a>]. A <a class="def" href="/books/n/gene/glossary/def-item/genotype/">genotype</a>/<a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> correlation is observed in the keratin disorder <a href="/books/n/gene/ebs/">epidermolysis bullosa simplex</a> (EBS), in which the more severe pathogenic variants occur in the helix boundary domains and those causing a milder phenotype occur within or outside these regions. To date this has not been observed in PC; possibly, pathogenic variants in these less conserved regions in <i>KRT6A</i>, <i>KRT6B</i>, <i>KRT6C</i>, <i>KRT16</i>, or <i>KRT17</i> are in general not severe enough to produce a clinical phenotype.</p><div class="iconblock whole_rhythm clearfix ten_col fig" id="figpcF2" co-legend-rid="figlgndpcF2"><a href="/books/NBK1280/figure/pc.F2/?report=objectonly" target="object" title="Figure 2. " class="img_link icnblk_img figpopup" rid-figpopup="figpcF2" rid-ob="figobpcF2"><img class="small-thumb" src="/books/NBK1280/bin/pc-Image002.gif" src-large="/books/NBK1280/bin/pc-Image002.jpg" alt="Figure 2. . Schematic diagram showing the basic protein structure of a keratin filament." /></a><div class="icnblk_cntnt" id="figlgndpcF2"><h4 id="pc.F2"><a href="/books/NBK1280/figure/pc.F2/?report=objectonly" target="object" rid-ob="figobpcF2">Figure 2. </a></h4><p class="float-caption no_bottom_margin">Schematic diagram showing the basic protein structure of a keratin filament. The &#x003b1;-helical rod domain is divided into four domains: 1A, 1B, 2A, and 2B, connected by non-helical linkers L1, L12, and L2. At the ends of the rod domain are the helix <a href="/books/NBK1280/figure/pc.F2/?report=objectonly" target="object" rid-ob="figobpcF2">(more...)</a></p></div></div><div id="pc.KRT6A"><h4><i>KRT6A</i></h4><p><b>Gene structure.</b> The <a class="def" href="/books/n/gene/glossary/def-item/cdna/">cDNA</a> comprises 2450 bp in nine exons. For a detailed summary of <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> and protein information, see <a href="/books/NBK1280/#pc.molgen.TA">Table A</a>, <b>Gene</b>.</p><p><b>Pathogenic variants.</b> The majority of pathogenic variants are <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a> variants; in some individuals, small <a class="def" href="/books/n/gene/glossary/def-item/in-frame/">in-frame</a> deletions/insertions and <a class="def" href="/books/n/gene/glossary/def-item/splice-site/">splice site</a> and <a class="def" href="/books/n/gene/glossary/def-item/nonsense-variant/">nonsense</a> variants have been reported. Most pathogenic variants occur in the highly conserved helix boundary motif domains located at either end of the alpha-helical keratin rod <a class="def" href="/books/n/gene/glossary/def-item/domain/">domain</a>. There are a number of recurrent pathogenic variants; the major ones for <a href="#pc.Nomenclature">PC-K6a</a>, located at Asn171, are either a single amino acid <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a> c.516_518del or a missense variant affecting the neighboring amino acid residue Asn172 (<a class="figpopup" href="/books/NBK1280/table/pc.T.selected_krt6a_pathogenic_variants/?report=objectonly" target="object" rid-figpopup="figpcTselectedkrt6apathogenicvariants" rid-ob="figobpcTselectedkrt6apathogenicvariants">Table 3</a>).</p><div id="pc.T.selected_krt6a_pathogenic_variants" class="table"><h3><span class="label">Table 3. </span></h3><div class="caption"><p>Selected <i>KRT6A</i> Pathogenic Variants</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1280/table/pc.T.selected_krt6a_pathogenic_variants/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__pc.T.selected_krt6a_pathogenic_variants_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_pc.T.selected_krt6a_pathogenic_variants_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">DNA Nucleotide Change<br />(Alias&#x000a0;<sup>1</sup>)</th><th id="hd_h_pc.T.selected_krt6a_pathogenic_variants_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Predicted Protein Change</th><th id="hd_h_pc.T.selected_krt6a_pathogenic_variants_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Reference Sequences</th></tr></thead><tbody><tr><td headers="hd_h_pc.T.selected_krt6a_pathogenic_variants_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.511A&#x0003e;G</td><td headers="hd_h_pc.T.selected_krt6a_pathogenic_variants_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Asn171Asp</td><td headers="hd_h_pc.T.selected_krt6a_pathogenic_variants_1_1_1_3" rowspan="5" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/entrez/viewer.fcgi?val=NM_005554.3" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri"><u>NM_005554.3</u></a><br /><a href="/entrez/viewer.fcgi?val=NP_005545.1" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri"><u>NP_005545.1</u></a></td></tr><tr><td headers="hd_h_pc.T.selected_krt6a_pathogenic_variants_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.511A&#x0003e;T</td><td headers="hd_h_pc.T.selected_krt6a_pathogenic_variants_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Asn171Tyr</td></tr><tr><td headers="hd_h_pc.T.selected_krt6a_pathogenic_variants_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.512A&#x0003e;G</td><td headers="hd_h_pc.T.selected_krt6a_pathogenic_variants_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Asn171Ser</td></tr><tr><td headers="hd_h_pc.T.selected_krt6a_pathogenic_variants_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.513C&#x0003e;A</td><td headers="hd_h_pc.T.selected_krt6a_pathogenic_variants_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Asn171Lys</td></tr><tr><td headers="hd_h_pc.T.selected_krt6a_pathogenic_variants_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.516_518del<br />(514_516delAAC)</td><td headers="hd_h_pc.T.selected_krt6a_pathogenic_variants_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Asn172del</td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div><p class="no_margin">Variants listed in the table have been provided by the authors. <i>GeneReviews</i> staff have not independently verified the classification of variants.</p></div></dd><dt></dt><dd><div><p class="no_margin"><i>GeneReviews</i> follows the standard naming conventions of the Human Genome Variation Society (<a href="http://varnomen.hgvs.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">varnomen<wbr style="display:inline-block"></wbr>​.hgvs.org</a>). See <a href="/books/n/gene/app3/">Quick Reference</a> for an explanation of nomenclature.</p></div></dd><dt>1. </dt><dd><div id="pc.TF.3.1"><p class="no_margin">Variant designation that does not conform to current naming conventions</p></div></dd></dl></div></div></div><p><b>Normal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b> The protein, keratin, type II cytoskeletal 6A (K6a keratin), consists of 564 amino acids. Keratins form a cytoskeletal intermediate filament network within all epithelial cells.</p><p><b>Abnormal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b> Pathogenic variants cause disruption of the cytoskeleton resulting in keratin filament aggregation leading to collapse of the cytoskeleton and cell fragility. The highly conserved helix boundary domains where the majority of pathogenic variants occur are critical during normal keratin filament assembly.</p></div><div id="pc.KRT6B"><h4><i>KRT6B</i></h4><p><b>Gene structure.</b> The <a class="def" href="/books/n/gene/glossary/def-item/cdna/">cDNA</a> comprises 2331 bp in nine exons (reference sequence <a href="/nuccore/119703752" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri"><u>NM_005555.3</u></a>). For a detailed summary of <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> and protein information, see <a href="/books/NBK1280/#pc.molgen.TA">Table A</a>, <b>Gene</b>.</p><p><b>Pathogenic variants.</b> The pathogenic variants reported to date are <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a> variants or small <a class="def" href="/books/n/gene/glossary/def-item/in-frame/">in-frame</a> deletions in either the highly conserved helix initiation or helix termination domains.</p><p><b>Normal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b> The protein, keratin, type II cytoskeletal 6B (K6b keratin), consists of 564 amino acids. Keratins form a cytoskeletal network within all epithelial cells.</p><p><b>Abnormal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b> Pathogenic variants cause disruption of the cytoskeleton resulting in keratin filament aggregation leading to collapse of the cytoskeleton and cell fragility. The highly conserved helix boundary domains where the majority of pathogenic variants occur are critical during normal keratin filament assembly.</p></div><div id="pc.KRT6C"><h4><i>KRT6C</i></h4><p><b>Gene structure.</b> The <a class="def" href="/books/n/gene/glossary/def-item/cdna/">cDNA</a> comprises 2345 bp in nine exons (reference sequence <a href="/entrez/viewer.fcgi?db=nucleotide&#x00026;val=155969696" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri"><u>NM_173086.4</u></a>). For a detailed summary of <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> and protein information, see <a href="/books/NBK1280/#pc.molgen.TA">Table A</a>, <b>Gene</b>.</p><p><b>Pathogenic variants.</b> The pathogenic variants reported to date are <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a> variants or small <a class="def" href="/books/n/gene/glossary/def-item/in-frame/">in-frame</a> deletions in regions encoding either the highly conserved helix initiation or helix termination domains.</p><p><b>Normal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b> The protein, keratin, type II cytoskeletal 6C (K6c keratin), consists of 564 amino acids (<a href="/protein/NP_775109.2" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NP_775109.2</a>). Keratins form a cytoskeletal network within all epithelial cells.</p><p><b>Abnormal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b> Pathogenic variants cause disruption of the cytoskeleton resulting in keratin filament aggregation leading to collapse of the cytoskeleton and cell fragility. The highly conserved helix boundary domains where the majority of pathogenic variants occur are critical during normal keratin filament assembly.</p></div><div id="pc.KRT16"><h4><i>KRT16</i></h4><p><b>Gene structure.</b> The <a class="def" href="/books/n/gene/glossary/def-item/cdna/">cDNA</a> comprises 1720 bp in eight exons (reference sequence <a href="/nuccore/163659905" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri"><u>NM_005557.3</u></a>). For a detailed summary of <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> and protein information, see <a href="/books/NBK1280/#pc.molgen.TA">Table A</a>, <b>Gene</b>.</p><p><b>Pathogenic variants.</b> The majority of pathogenic variants are <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a> variants; in some individuals, small <a class="def" href="/books/n/gene/glossary/def-item/in-frame/">in-frame</a> deletions and <a class="def" href="/books/n/gene/glossary/def-item/nonsense-variant/">nonsense</a> variants have been reported. Most pathogenic variants occur in the highly conserved helix boundary motif domains located at either end of the alpha-helical keratin rod <a class="def" href="/books/n/gene/glossary/def-item/domain/">domain</a>.</p><p><b>Normal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b> The protein, keratin, type I cytoskeletal 16 (K16), consists of 473 amino acids. Keratins form a cytoskeletal network within all epithelial cells.</p><p><b>Abnormal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b> Pathogenic variants cause disruption of the cytoskeleton resulting in keratin filament aggregation leading to collapse of the cytoskeleton and cell fragility. The highly conserved helix boundary domains where the majority of pathogenic variants occur are critical during normal keratin filament assembly.</p></div><div id="pc.KRT17"><h4><i>KRT17</i></h4><p><b>Gene structure.</b> The <a class="def" href="/books/n/gene/glossary/def-item/cdna/">cDNA</a> comprises 1574 bp in eight exons. For a detailed summary of <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> and protein information, see <a href="/books/NBK1280/#pc.molgen.TA">Table A</a>, <b>Gene</b>.</p><p><b>Pathogenic variants.</b> The majority of pathogenic variants are <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a> variants; in some individuals, small <a class="def" href="/books/n/gene/glossary/def-item/in-frame/">in-frame</a> deletions have been reported. The majority of pathogenic variants in <i>KRT17</i> occur in the helix initiation motif, in which several recurrent pathogenic variants have been observed, particularly c.275A&#x0003e;G.</p><div id="pc.T.selected_krt17_pathogenic_variants" class="table"><h3><span class="label">Table 4. </span></h3><div class="caption"><p>Selected <i>KRT17</i> Pathogenic Variants</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1280/table/pc.T.selected_krt17_pathogenic_variants/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__pc.T.selected_krt17_pathogenic_variants_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_pc.T.selected_krt17_pathogenic_variants_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">DNA Nucleotide Change</th><th id="hd_h_pc.T.selected_krt17_pathogenic_variants_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Predicted Protein Change</th><th id="hd_h_pc.T.selected_krt17_pathogenic_variants_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Reference Sequences</th></tr></thead><tbody><tr><td headers="hd_h_pc.T.selected_krt17_pathogenic_variants_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.275A&#x0003e;G</td><td headers="hd_h_pc.T.selected_krt17_pathogenic_variants_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Asn92Ser</td><td headers="hd_h_pc.T.selected_krt17_pathogenic_variants_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/entrez/viewer.fcgi?val=NM_000422.2" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri"><u>NM_000422.2</u></a><br /><a href="/entrez/viewer.fcgi?val=NP_000413.1" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri"><u>NP_000413.1</u></a></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div><p class="no_margin">Note on variant classification: Variants listed in the table have been provided by the authors. <i>GeneReviews</i> staff have not independently verified the classification of variants.</p></div></dd><dt></dt><dd><div><p class="no_margin">Note on nomenclature: <i>GeneReviews</i> follows the standard naming conventions of the Human Genome Variation Society (<a href="http://varnomen.hgvs.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">varnomen<wbr style="display:inline-block"></wbr>​.hgvs.org</a>). See <a href="/books/n/gene/app3/">Quick Reference</a> for an explanation of nomenclature.</p></div></dd></dl></div></div></div><p><b>Normal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b> The protein, keratin, type I cytoskeletal 17 (K17), consists of 432 amino acids. Keratins form a cytoskeletal network within all epithelial cells.</p><p><b>Abnormal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b> Pathogenic variants cause disruption of the cytoskeleton resulting in keratin filament aggregation leading to collapse of the cytoskeleton and cell fragility. The highly conserved helix boundary domains where the majority of pathogenic variants occur are critical during normal keratin filament assembly.</p></div></div></div><div id="pc.References"><h2 id="_pc_References_">References</h2><div id="pc.Literature_Cited"><h3>Literature Cited</h3><ul class="simple-list"><li class="half_rhythm"><div class="bk_ref" id="pc.REF.covello.1998.475">Covello SP, Smith FJD, Sillevis Smitt JH, Paller AS, Munro CS, Jonkman MF, Uitto J, McLean WHI. Keratin 17 mutations cause either steatocystoma multiplex or pachyonychia congenita type 2. <span><span class="ref-journal">Br J Dermatol. </span>1998;<span class="ref-vol">139</span>:475–80.</span> [<a href="/pubmed/9767294" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 9767294</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="pc.REF.deklotz.2017.990">DeKlotz CMC, Schwartz ME, Milstone LM. Nail removal in pachyonychia congenita: patient-reported survey outcomes. <span><span class="ref-journal">J Am Acad Dermatol. </span>2017;<span class="ref-vol">76</span>:990–2.</span> [<a href="/pubmed/28411774" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 28411774</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="pc.REF.duchatelet.2014.675">Duchatelet S, Guibbal L, de Veer S, Fraitag S, Nitschk&#x000e9; P, Zarhrate M, Bodemer C, Hovnanian A. Olmsted syndrome with erythromelalgia caused by recessive transient receptor potential vanilloid 3 mutations. <span><span class="ref-journal">Br J Dermatol. </span>2014;<span class="ref-vol">171</span>:675–8.</span> [<a href="/pubmed/24606194" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 24606194</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="pc.REF.eliason.2012.680">Eliason MJ, Leachman SA, Feng BJ, Schwartz ME, Hansen CD. A review of the clinical phenotype of 254 patients with genetically confirmed pachyonychia congenita. <span><span class="ref-journal">J Am Acad Dermatol. </span>2012;<span class="ref-vol">67</span>:680–6.</span> [<a href="/pubmed/22264670" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22264670</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="pc.REF.feng.2003.452">Feng YG, Xiao SX, Ren XR, Wang WQ, Liu A, Pan M. Keratin 17 mutation in pachyonychia congenita type 2 with early onset sebaceous cysts. <span><span class="ref-journal">Br J Dermatol. </span>2003;<span class="ref-vol">148</span>:452–5.</span> [<a href="/pubmed/12653736" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12653736</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="pc.REF.fu.2011.1025">Fu T, Leachman SA, Wilson NJ, Smith FJD, Schwartz ME, Tang JY. Genotype-phenotype correlations among pachyonychia congenita patients with K16 mutations. <span><span class="ref-journal">J Invest Dermatol. </span>2011;<span class="ref-vol">131</span>:1025–8.</span> [<a href="/pmc/articles/PMC3775566/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3775566</span></a>] [<a href="/pubmed/21160496" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 21160496</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="pc.REF.goldberg.2014.279">Goldberg I, Fruchter D, Meilick A, Schwartz ME, Sprecher E. Best treatment practices for pachyonychia congenita. <span><span class="ref-journal">JEADV. </span>2014;<span class="ref-vol">28</span>:279–85.</span> [<a href="/pubmed/23363249" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23363249</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="pc.REF.gonz_lezramos.2016.32">Gonz&#x000e1;lez-Ramos J, Sendagorta-Cud&#x000f3;s E, Gonz&#x000e1;lez-L&#x000f3;pez G, Mayor-Ibarguren A, Feltes-Ochoa R, Herranz-Pinto P. Efficacy of botulinum toxin in pachyonychia congenita type 1: report of two new cases. <span><span class="ref-journal">Dermatol Ther. </span>2016;<span class="ref-vol">29</span>:32–6.</span> [<a href="/pubmed/26445325" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 26445325</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="pc.REF.gruber.2012.e193">Gruber R, Edlinger M, Kaspar RL, Hansen CD, Leachman S, Milstone LM, Smith FJ, Sidoroff A, Fritsch PO, Schmuth M. An appraisal of oral retinoids in the treatment of pachyonychia congenita. <span><span class="ref-journal">J Am Acad Dermatol. </span>2012;<span class="ref-vol">66</span>:e193–9.</span> [<a href="/pubmed/21601946" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 21601946</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="pc.REF.hale.2015.1447">Hale GI, Wilson NJ, Smith FJ, Wylie G, Schwartz ME, Zamiri M. Mutations in GJB6 causing phenotype resembling pachyonychia congenita. <span><span class="ref-journal">Br J Dermatol. </span>2015;<span class="ref-vol">172</span>:1447–9.</span> [<a href="/pubmed/25385569" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 25385569</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="pc.REF.hickerson.2009.82">Hickerson RP, Leake D, Pho LN, Leachman SA, Kaspar RL. Rapamycin selectively inhibits expression of an inducible keratin (K6a) in human keratinocytes and improves symptoms in pachyonychia congenita patients. <span><span class="ref-journal">J Dermatol Sci. </span>2009;<span class="ref-vol">56</span>:82–8.</span> [<a href="/pubmed/19699613" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19699613</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="pc.REF.hickerson.2008.594">Hickerson RP, Smith FJD, Reeves RE, Contag CH, Leake D, Leachman SA, Milstone LM, McLean WHI, Kaspar RL. Single-nucleotide-specific siRNA targeting in a dominant-negative skin model. <span><span class="ref-journal">J Invest Dermatol. </span>2008;<span class="ref-vol">128</span>:594–605.</span> [<a href="/pubmed/17914454" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17914454</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="pc.REF.kasparis.2016.884">Kasparis C, Reid D, Wilson NJ, Okur V, Cole C, Hansen CD, Bosse K, Betz RC, Khan M, Smith FJD. Isolated recessive nail dysplasia caused by <em>FZD6</em> mutations: report of three families and review of the literature. <span><span class="ref-journal">Clin Exp Dermatol. </span>2016;<span class="ref-vol">41</span>:884–9.</span> [<a href="/pmc/articles/PMC5132090/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC5132090</span></a>] [<a href="/pubmed/27786367" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 27786367</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="pc.REF.leachman.2008.151">Leachman SA, Hickerson RP, Hull PR, Smith FJD, Milstone LM, Lane EB, Bale SJ, Roop DR, McLean WHI, Kaspar RL. Therapeutic siRNAs for dominant genetic skin disorders including pachyonychia congenita. <span><span class="ref-journal">J Dermatol Sci. </span>2008;<span class="ref-vol">51</span>:151–7.</span> [<a href="/pmc/articles/PMC2587483/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2587483</span></a>] [<a href="/pubmed/18495438" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 18495438</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="pc.REF.leachman.2010.442">Leachman SA, Hickerson RP, Schwartz ME, Bullough EE, Hutcherson SL, Boucher KM, Hansen CD, Eliason MJ, Srivatsa GS, Kornbrust DJ, Smith FJD, McLean WHI, Milstone LM, Kaspar RL. First-in-human mutation-targeted siRNA phase Ib trial of an inherited skin disorder. <span><span class="ref-journal">Mol Ther. </span>2010;<span class="ref-vol">18</span>:442–6.</span> [<a href="/pmc/articles/PMC2839285/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2839285</span></a>] [<a href="/pubmed/19935778" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19935778</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="pc.REF.leachman.2005.3">Leachman SA, Kaspar RL, Fleckman P, Florell SR, Smith FJD, McLean WHI, Lunny DP, Milstone LM, van Steensel MA, Munro CS, O'Toole EA, Celebi JT, Kansky A, Lane EB. Clinical and pathological features of pachyonychia congenita. <span><span class="ref-journal">J Investig Dermatol Symp Proc. </span>2005;<span class="ref-vol">10</span>:3–17.</span> [<a href="/pubmed/16250204" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16250204</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="pc.REF.liao.2007.199">Liao H, Sayers JM, Wilson NJ, Irvine AD, Mellerio JE, Baselga E, Bayliss SJ, Uliana V, Fimiani M, Lane EB, McLean WHI, Leachman SA, Smith FJD. A spectrum of mutations in keratins K6a, K16 and K17 causing pachyonychia congenita. <span><span class="ref-journal">J Dermatol Sci. </span>2007;<span class="ref-vol">48</span>:199–205.</span> [<a href="/pubmed/17719747" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17719747</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="pc.REF.lin.2012.558">Lin Z, Chen Q, Lee M, Cao X, Zhang J, Ma D, Chen L, Hu X, Wang H, Wang X, Zhang P, Liu X, Guan L, Tang Y, Yang H, Tu P, Bu D, Zhu X, Wang K, Li R, Yang Y. Exome sequencing reveals mutations in TRPV3 as a cause of Olmsted syndrome. <span><span class="ref-journal">Am J Hum Genet. </span>2012;<span class="ref-vol">90</span>:558–64.</span> [<a href="/pmc/articles/PMC3309189/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3309189</span></a>] [<a href="/pubmed/22405088" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22405088</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="pc.REF.lovgren.2017.1345">Lovgren ML, McAleer MA, Irvine AD, Wilson NJ, Tavadia S, Schwartz ME, Cole C, Sandilands A, Smith FJD, Zamiri M. Mutations in desmoglein 1 cause diverse inherited palmoplantar keratoderma phenotypes: implications for genetic screening. <span><span class="ref-journal">Br J Dermatol. </span>2017;<span class="ref-vol">176</span>:1345–50.</span> [<a href="/pmc/articles/PMC5485079/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC5485079</span></a>] [<a href="/pubmed/27534273" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 27534273</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="pc.REF.mclean.2011.1015">McLean WHI, Hansen CD, Eliason M, Smith FJD. The phenotypic and molecular genetic features of pachyonychia congenita. <span><span class="ref-journal">J Invest Dermatol. </span>2011;<span class="ref-vol">131</span>:1015–7.</span> [<a href="/pubmed/21430705" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 21430705</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="pc.REF.pan.2016.2843">Pan B, Byrnes K, Schwartz M, Hansen CD, Campbell CM, Krupiczojc M, Caterina MJ, Polydefkis M. Peripheral neuropathic changes in pachyonychia congenita. <span><span class="ref-journal">Pain. </span>2016;<span class="ref-vol">157</span>:2843–53.</span> [<a href="/pubmed/27776012" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 27776012</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="pc.REF.pho.2011.1077">Pho LN, Smith FJD, Konecki D, Bale S, McLean WHI, Cohen B, Eliason M, Leachman SA. Paternal germ cell mosaicism in autosomal dominant pachyonychia congenita. <span><span class="ref-journal">Arch Dermatol. </span>2011;<span class="ref-vol">147</span>:1077–80.</span> [<a href="/pubmed/21576551" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 21576551</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="pc.REF.pohler.2012.1272">Pohler E, Mamai O, Hirst J, Zamiri M, Horn H, Nomura T, Irvine AD, Moran B, Wilson NJ, Smith FJD, Goh CS, Sandilands A, Cole C, Barton GJ, Evans AT, Shimizu H, Akiyama M, Suehiro M, Konohana I, Shboul M, Teissier S, Boussofara L, Denguezli M, Saad A, Gribaa M, Dopping-Hepenstal PJ, McGrath JA, Brown SJ, Goudie DR, Reversade B, Munro CS, McLean WHI. Haploinsufficiency for AAGAB causes clinically heterogeneous forms of punctate palmoplantar keratoderma. <span><span class="ref-journal">Nat Genet. </span>2012;<span class="ref-vol">44</span>:1272–6.</span> [<a href="/pmc/articles/PMC3836166/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3836166</span></a>] [<a href="/pubmed/23064416" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23064416</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="pc.REF.schwartz.2013.42">Schwartz ME, Zimmerman GM, Smith FJD, Sprecher E. Pachyonychia Congenita Project: a partnership of patient and medical professional. <span><span class="ref-journal">J Derm Nurses Association. </span>2013;<span class="ref-vol">5</span>:42–47.</span></div></li><li class="half_rhythm"><div class="bk_ref" id="pc.REF.shah.2014.146">Shah S, Boen M, Kenner-Bell B, Schwartz M, Rademaker A, Paller AS. Pachyonychia congenita in pediatric patients: natural history, features, and impact. <span><span class="ref-journal">JAMA Dermatol. </span>2014;<span class="ref-vol">150</span>:146–53.</span> [<a href="/pubmed/24132595" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 24132595</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="pc.REF.spaunhurst.2012.875">Spaunhurst KM, Hogendorf AM, Smith FJD, Lingala B, Schwartz ME, Cywinska-Bernas A, Zeman KJ, Tang JY. Pachyonychia congenita patients with mutations in KRT6A have more extensive disease compared with patients who have mutations in KRT16. <span><span class="ref-journal">Br J Dermatol. </span>2012;<span class="ref-vol">166</span>:875–8.</span> [<a href="/pubmed/22098151" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22098151</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="pc.REF.szeverenyi.2008.351">Szeverenyi I, Cassidy AJ, Chung CW, Lee BT, Common JE, Ogg SC, Chen H, Sim SY, Goh WL, Ng KW, Simpson JA, Chee LL, Eng GH, Li B, Lunny DP, Chuon D, Venkatesh A, Khoo KH, McLean WHI, Lim YP, Lane EB. The human intermediate filament database: comprehensive information on a gene family involved in many human diseases. <span><span class="ref-journal">Hum Mutat. </span>2008;<span class="ref-vol">29</span>:351–60.</span> [<a href="/pubmed/18033728" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 18033728</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="pc.REF.swartling.2010.1072">Swartling C, Karlqvist M, Hymnelius K, Weis J, Vahlquist A. Botulinum toxin in the treatment of sweat-worsened foot problems in patients with epidermolysis bullosa simplex and pachyonychia congenita. <span><span class="ref-journal">Br J Dermatol. </span>2010;<span class="ref-vol">163</span>:1072–6.</span> [<a href="/pubmed/20618323" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 20618323</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="pc.REF.swartling.2006.763">Swartling C, Vahlquist A. Treatment of pachyonychia congenita with plantar injections of botulinum toxin. <span><span class="ref-journal">Br J Dermatol. </span>2006;<span class="ref-vol">154</span>:763–5.</span> [<a href="/pubmed/16536826" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16536826</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="pc.REF.wallis.2016.26">Wallis T, Poole CD, Hoggart B. Can skin disease cause neuropathic pain? A study in pachyonychia congenita. <span><span class="ref-journal">Clin Exp Dermatol. </span>2016;<span class="ref-vol">41</span>:26–33.</span> [<a href="/pubmed/26358843" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 26358843</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="pc.REF.wilson.2015.2879">Wilson NJ, Cole C, Milstone LM, Kiszewski AE, Hansen CD, O'Toole EA, Schwartz ME, McLean WHI, Smith FJD. Expanding the phenotypic spectrum of Olmsted syndrome. <span><span class="ref-journal">J Invest Dermatol. </span>2015;<span class="ref-vol">135</span>:2879–83.</span> [<a href="/pmc/articles/PMC4652067/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4652067</span></a>] [<a href="/pubmed/26067147" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 26067147</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="pc.REF.wilson.2013.58">Wilson NJ, Hansen CD, Azkur D, Kocabas CN, Metin A, Coskun Z, Schwartz ME, Hull PR, McLean WHI, Smith FJD. Recessive mutations in the gene encoding frizzled 6 cause twenty nail dystrophy--expanding the differential diagnosis for pachyonychia congenita. <span><span class="ref-journal">J Dermatol Sci. </span>2013;<span class="ref-vol">70</span>:58–60.</span> [<a href="/pubmed/23374899" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23374899</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="pc.REF.wilson.2011.1018">Wilson NJ, Leachman SA, Hansen CD, McMullan AC, Milstone LM, Schwartz ME, McLean WHI, Hull PR, Smith FJD. A large mutational study in pachyonychia congenita. <span><span class="ref-journal">J Invest Dermatol. </span>2011;<span class="ref-vol">131</span>:1018–24.</span> [<a href="/pubmed/21326300" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 21326300</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="pc.REF.wilson.2010.425">Wilson NJ, Messenger AG, Leachman SA, O'Toole EA, Lane EB, McLean WHI, Smith FJD. Keratin K6c mutations cause focal palmoplantar keratoderma. <span><span class="ref-journal">J Invest Dermatol. </span>2010;<span class="ref-vol">130</span>:425–9.</span> [<a href="/pubmed/19609311" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19609311</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="pc.REF.wilson.2014.343">Wilson NJ, O'Toole E, Milstone LM, Hansen CD, Shepherd AA, Al-Asadi E, Schwartz ME, McLean WHI, Sprecher E, Smith FJD. The molecular genetic analysis of the expanding pachyonychia congenita case collection. <span><span class="ref-journal">Br J Dermatol. </span>2014;<span class="ref-vol">171</span>:343–55.</span> [<a href="/pmc/articles/PMC4282083/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4282083</span></a>] [<a href="/pubmed/24611874" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 24611874</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="pc.REF.zhao.2011.1045">Zhao Y, Gartner U, Smith FJD, McLean WHI. Statins downregulate K6a promoter activity: a possible therapeutic avenue for pachyonychia congenita. <span><span class="ref-journal">J Invest Dermatol. </span>2011;<span class="ref-vol">131</span>:1045–52.</span> [<a href="/pubmed/21390048" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 21390048</span></a>]</div></li></ul></div></div><div id="pc.Chapter_Notes"><h2 id="_pc_Chapter_Notes_">Chapter Notes</h2><div id="pc.Author_Notes"><h3>Author Notes</h3><p><a href="http://www.transderminc.com/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri"><u>TransDerm, Inc</u></a> is a therapeutic company dedicated to finding treatment for rare skin disorders.</p></div><div id="pc.Acknowledgments"><h3>Acknowledgments</h3><p>We thank the many <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals and the clinicians without whose input our work into the genetic basis of PC would not have been possible. Thanks to Holly Evans of PC Project for helping with IPCRR data preparation. Research into the genetic basis and treatment of keratin disorders in the WHIM lab has been supported by The Wellcome Trust, DEBRA UK, and The PC Project.</p></div><div id="pc.Author_History"><h3>Author History</h3><p>C David Hansen, MD (2011-present)<br />Peter R Hull, MD, PhD, FRCPC (2011-present)<br />Roger L Kaspar, PhD (2006-present)<br />Sancy A Leachman, MD, PhD; University of Utah (2006-2014)<br />WH Irwin McLean, DSc, FRSE (2006-present)<br />Leonard M Milstone, MD; Yale University (2011-2017)<br />Edel O'Toole, MD, PhD, FRCPI, FRCP (2014-present)<br />Mary E Schwartz, LLD; PC Project (2006-2017)<br />Frances JD Smith, PhD (2006-present)<br />Eli Sprecher, MD, PhD (2011-present)<br />Maurice van Steensel, MD, PhD; University Hospital Maastricht (2014-2017)</p></div><div id="pc.Revision_History"><h3>Revision History</h3><ul><li class="half_rhythm"><div>30 November 2017 (ma) Comprehensive update posted live</div></li><li class="half_rhythm"><div>24 July 2014 (me) Comprehensive updated posted live</div></li><li class="half_rhythm"><div>1 December 2011 (me) Comprehensive update posted live</div></li><li class="half_rhythm"><div>25 June 2009 (me) Comprehensive update posted live</div></li><li class="half_rhythm"><div>6 December 2007 (cd) Revision: clarification of PC phenotypes</div></li><li class="half_rhythm"><div>27 January 2006 (me) Review posted live</div></li><li class="half_rhythm"><div>14 July 2005 (rlk) Original submission</div></li></ul></div></div><div id="bk_toc_contnr"></div></div></div>
            <div class="post-content"><div><div class="half_rhythm"><a href="/books/about/copyright/">Copyright</a> © 1993-2019, University of Washington, Seattle. GeneReviews is
a registered trademark of the University of Washington, Seattle. All rights
reserved.<p class="small">GeneReviews® chapters are owned by the University of Washington. Permission is
hereby granted to reproduce, distribute, and translate copies of content materials for
noncommercial research purposes only, provided that (i) credit for source (<a href="http://www.genereviews.org/" ref="pagearea=meta&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">http://www.genereviews.org/</a>) and copyright (© 1993-2019 University of
Washington) are included with each copy; (ii) a link to the original material is provided
whenever the material is published elsewhere on the Web; and (iii) reproducers,
distributors, and/or translators comply with the <a href="/books/n/gene/GRcopyright_permiss/">GeneReviews® Copyright Notice and Usage
Disclaimer</a>. No further modifications are allowed. For clarity, excerpts
of GeneReviews chapters for use in lab reports and clinic notes are a permitted
use.</p><p class="small">For more information, see the <a href="/books/n/gene/GRcopyright_permiss/">GeneReviews® Copyright Notice and Usage
Disclaimer</a>.</p><p class="small">For questions regarding permissions or whether a specified use is allowed,
contact: <a href="mailto:dev@null" data-email="ude.wu@tssamda" class="oemail">ude.wu@tssamda</a>.</p></div><div class="small"><span class="label">Bookshelf ID: NBK1280</span><span class="label">PMID: <a href="/pubmed/20301457" title="PubMed record of this page" ref="pagearea=meta&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">20301457</a></span></div><div style="margin-top:2em" class="bk_noprnt"><a class="bk_cntns" href="/books/n/gene/">GeneReviews by Title</a><div class="pagination bk_noprnt"><a class="active page_link prev" href="/books/n/gene/pura-dis/" title="Previous page in this title">&lt; Prev</a><a class="active page_link next" href="/books/n/gene/phs/" title="Next page in this title">Next &gt;</a></div></div></div></div>
            
        </div>

        <!-- Custom content below content -->
        <div class="col4">
            
        </div>
        
        
        <!-- Book content -->
        
        <!-- Custom contetnt below bottom nav -->
        <div class="col5">
            
        </div>
    </div>

    <div id="rightcolumn" class="four_col col last">
        <!-- Custom content above discovery portlets -->
        <div class="col6">
            <div id="ncbi_share_book"><a href="#" class="ncbi_share" data-ncbi_share_config="popup:false,shorten:true" ref="id=NBK1280&amp;db=books">Share</a></div>

        </div>
        <div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Views</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="PDF_download" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="/books/NBK1280/?report=reader">PubReader</a></li><li><a href="/books/NBK1280/?report=printable">Print View</a></li><li><a data-jig="ncbidialog" href="#_ncbi_dlg_citbx_NBK1280" data-jigconfig="width:400,modal:true">Cite this Page</a><div id="_ncbi_dlg_citbx_NBK1280" style="display:none" title="Cite this Page"><div class="bk_tt">Smith FJD, Hansen CD, Hull PR, et al. Pachyonychia Congenita. 2006 Jan 27 [Updated 2017 Nov 30]. In: Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2019. <span class="bk_cite_avail"></span></div></div></li><li><a href="/books/NBK1280/pdf/Bookshelf_NBK1280.pdf">PDF version of this page</a> (452K)</li><li><a href="#" class="toggle-glossary-link" title="Enable/disable links to the glossary">Disable Glossary Links</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>In this GeneReview</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="page-toc" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="#pc.Summary" ref="log$=inpage&amp;link_id=inpage">Summary</a></li><li><a href="#pc.Diagnosis" ref="log$=inpage&amp;link_id=inpage">Diagnosis</a></li><li><a href="#pc.Clinical_Characteristics" ref="log$=inpage&amp;link_id=inpage">Clinical Characteristics</a></li><li><a href="#pc.Genetically_Related_Allelic_Disorders" ref="log$=inpage&amp;link_id=inpage">Genetically Related (Allelic) Disorders</a></li><li><a href="#pc.Differential_Diagnosis" ref="log$=inpage&amp;link_id=inpage">Differential Diagnosis</a></li><li><a href="#pc.Management" ref="log$=inpage&amp;link_id=inpage">Management</a></li><li><a href="#pc.Genetic_Counseling" ref="log$=inpage&amp;link_id=inpage">Genetic Counseling</a></li><li><a href="#pc.Resources" ref="log$=inpage&amp;link_id=inpage">Resources</a></li><li><a href="#pc.Molecular_Genetics" ref="log$=inpage&amp;link_id=inpage">Molecular Genetics</a></li><li><a href="#pc.References" ref="log$=inpage&amp;link_id=inpage">References</a></li><li><a href="#pc.Chapter_Notes" ref="log$=inpage&amp;link_id=inpage">Chapter Notes</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>GeneReviews Links</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="source-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="/books/n/gene/advanced/"><i>GeneReviews</i> Advanced Search</a></li><li><a href="/books/n/gene/glossary/"><i>GeneReviews</i> Glossary</a></li><li><a href="/books/n/gene/resource_mats/">Resource Materials</a> <span class="bk_hlight1">NEW FEATURE</span></li><li><a href="/books/n/gene/updates/">New in <i>GeneReviews</i></a></li><li><a href="/books/n/gene/authors/">Author List</a></li><li><a href="/books/n/gene/prospective_authors/">For Current/Prospective Authors</a></li><li><a href="/books/n/gene/GRpersonnel/"><i>GeneReviews</i> Personnel</a></li><li><a href="/books/n/gene/howto_linkin/">Download/Link to <i>GeneReviews</i></a></li><li><a href="/books/n/gene/contact_us/">Contact Us</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Tests in GTR by Gene</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="document-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=3872[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">KRT17</a></li><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=286887[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">KRT6C</a></li><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=3854[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">KRT6B</a></li><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=3868[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">KRT16</a></li><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=3853[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">KRT6A</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Related information</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="discovery_db_links" id="Shutter"></a></div><div class="portlet_content"><ul><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=omim&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_omim&amp;IdsFromResult=1481962" ref="log$=recordlinks">OMIM</a><div class="brieflinkpop offscreen_noflow">Related OMIM records</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=pmc&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_pmc_refs&amp;IdsFromResult=1481962" ref="log$=recordlinks">PMC</a><div class="brieflinkpop offscreen_noflow">PubMed Central citations</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=pubmed&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_pubmed_refs&amp;IdsFromResult=1481962" ref="log$=recordlinks">PubMed</a><div class="brieflinkpop offscreen_noflow">Links to PubMed</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=gene&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_gene&amp;IdsFromResult=1481962" ref="log$=recordlinks">Gene</a><div class="brieflinkpop offscreen_noflow">Locus Links</div></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Similar articles in PubMed</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="PBooksDiscovery_RA" id="Shutter"></a></div><div class="portlet_content"><ul><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/28794556" ref="ordinalpos=1&amp;linkpos=1&amp;log$=relatedarticles&amp;logdbfrom=pubmed">Keratin 17 Mutations in Four Families from India with Pachyonychia Congenita.</a><span class="source">[Indian J Dermatol. 2017]</span><div class="brieflinkpop offscreen_noflow">Keratin 17 Mutations in Four Families from India with Pachyonychia Congenita.<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Agarwala M, Salphale P, Peter D, Wilson NJ, Pulimood S, Schwartz ME, Smith FJD. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">Indian J Dermatol. 2017 Jul-Aug; 62(4):422-426. </em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/31777952" ref="ordinalpos=1&amp;linkpos=2&amp;log$=relatedarticles&amp;logdbfrom=pubmed">Symptomatic mucosal involvement in pachyonychia congenita: the challenges in infants and young children.</a><span class="source">[Br J Dermatol. 2019]</span><div class="brieflinkpop offscreen_noflow">Symptomatic mucosal involvement in pachyonychia congenita: the challenges in infants and young children.<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Goldberg I, Mashiah J, Kutz A, Derowe A, Warshauer E, Schwartz ME, Smith F, Sprecher E, Hansen CD. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">Br J Dermatol. 2019 Nov 28; . Epub 2019 Nov 28.</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/21326300" ref="ordinalpos=1&amp;linkpos=3&amp;log$=relatedarticles&amp;logdbfrom=pubmed">A large mutational study in pachyonychia congenita.</a><span class="source">[J Invest Dermatol. 2011]</span><div class="brieflinkpop offscreen_noflow">A large mutational study in pachyonychia congenita.<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Wilson NJ, Leachman SA, Hansen CD, McMullan AC, Milstone LM, Schwartz ME, McLean WH, Hull PR, Smith FJ. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">J Invest Dermatol. 2011 May; 131(5):1018-24. Epub 2011 Feb 17.</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/27041546" ref="ordinalpos=1&amp;linkpos=4&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Pachyonychia Congenita: A Spectrum of KRT6a Mutations in Australian Patients.</a><span class="source">[Pediatr Dermatol. 2016]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Pachyonychia Congenita: A Spectrum of KRT6a Mutations in Australian Patients.<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Forrest CE, Casey G, Mordaunt DA, Thompson EM, Gordon L. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">Pediatr Dermatol. 2016 May; 33(3):337-42. Epub 2016 Apr 4.</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/10464680" ref="ordinalpos=1&amp;linkpos=5&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> [Pachyonychia congenita. Keratin gene mutations with pleiotropic effect].</a><span class="source">[Hautarzt. 1999]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> [Pachyonychia congenita. Keratin gene mutations with pleiotropic effect].<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Swensson O. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">Hautarzt. 1999 Jul; 50(7):483-90. </em></div></div></li></ul><a class="seemore" href="/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed_reviews&amp;uid=20301457" ref="ordinalpos=1&amp;log$=relatedreviews_seeall&amp;logdbfrom=pubmed">See reviews...</a><a class="seemore" href="/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed&amp;uid=20301457" ref="ordinalpos=1&amp;log$=relatedarticles_seeall&amp;logdbfrom=pubmed">See all...</a></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Recent Activity</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="recent_activity" id="Shutter"></a></div><div class="portlet_content"><div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" id="HTDisplay" class=""><div class="action"><a href="javascript:historyDisplayState('ClearHT')">Clear</a><a href="javascript:historyDisplayState('HTOff')" class="HTOn">Turn Off</a><a href="javascript:historyDisplayState('HTOn')" class="HTOff">Turn On</a></div><ul id="activity"><li class="ra_rcd ralinkpopper two_line"><a class="htb ralinkpopperctrl" ref="log$=activity&amp;linkpos=1" href="/portal/utils/pageresolver.fcgi?recordid=5dfc940775f66d18aaf7c64b">Pachyonychia Congenita - GeneReviews®</a><div class="ralinkpop offscreen_noflow">Pachyonychia Congenita - GeneReviews®<div class="brieflinkpopdesc"></div></div><div class="tertiary"></div></li></ul><p class="HTOn">Your browsing activity is empty.</p><p class="HTOff">Activity recording is turned off.</p><p id="turnOn" class="HTOff"><a href="javascript:historyDisplayState('HTOn')">Turn recording back on</a></p><a class="seemore" href="/sites/myncbi/recentactivity">See more...</a></div></div></div>
        
        <!-- Custom content below discovery portlets -->
        <div class="col7">
            
        </div>
    </div>
</div>

<!-- Custom content after all -->
<div class="col8">
    
</div>
<div class="col9">
    
</div>

<script type="text/javascript" src="/corehtml/pmc/js/jquery.scrollTo-1.4.2.js"></script>
<script type="text/javascript">
    (function($){
        $('.skiplink').each(function(i, item){
            var href = $($(item).attr('href'));
            href.attr('tabindex', '-1').addClass('skiptarget'); // ensure the target can receive focus
            $(item).on('click', function(event){
                event.preventDefault();
                $.scrollTo(href, 0, {
                    onAfter: function(){
                        href.focus();
                    }
                });
            });
        });
    })(jQuery);
</script>
                        </div>
                        <div class="bottom">
                            
                            <div id="NCBIFooter_dynamic">
    <a id="help-desk-link" class="help_desk" href="" target="_blank">Support Center</a>
    <a id="help-desk-link" class="help_desk" href="https://support.ncbi.nlm.nih.gov/ics/support/KBList.asp?Time=2019-12-20T04:27:35-05:00&amp;Snapshot=%2Fprojects%2Fbooks%2FPBooks@5.22&amp;Host=portal102&amp;ncbi_phid=CE8903AFDFC85B810000000007400377&amp;ncbi_session=CE8903AFDFC94071_1856SID&amp;from=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fbooks%2FNBK1280%2F&amp;Db=pmc&amp;folderID=134&amp;Ncbi_App=bookshelf&amp;Page=literature&amp;style=classic&amp;deptID=28049" target="_blank">Support Center</a>
    
</div>

                            <div class="footer" id="footer">
    
    <div class="subfooter"> </div><script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/preloaderWidget.js"> </script>
    <div id="external-disclaimer" class="offscreen_noflow">
        External link. Please review our <a href="https://www.nlm.nih.gov/privacy.html">privacy policy</a>.
    </div>    
    <div id="ncbifooter" class="contact_info">      
        <div id="footer-contents-right">
            <div id="nlm_thumb_logo">
                <a href="https://www.nlm.nih.gov" title="NLM">NLM</a>
            </div>
            <div id="nih_thumb_logo">
                <a href="https://www.nih.gov" title="NIH">NIH</a>
            </div>
            <div id="hhs_thumb_logo">
                <a href="https://www.hhs.gov" title="DHHS">DHHS</a>
            </div>
            <div id="usagov_thumb_logo">
                <a href="https://www.usa.gov" title="USA.gov">USA.gov</a>
            </div>         
        </div>
        
        <div id="footer-contents-left">
            <p class="address vcard">
                <span class="url">
                    <a class="fn url newdomain" href="https://www.ncbi.nlm.nih.gov">National Center for
                        Biotechnology Information</a>,
                </span> <span class="org url newdomain"><a href="https://www.nlm.nih.gov/">U.S. National Library of Medicine</a></span>
                <span class="adr">
                    <span class="street-address">8600 Rockville Pike</span>, <span class="locality">Bethesda</span>
                    <span class="region">MD</span>, <span class="postal-code">20894</span>
                    <span class="country-name">USA</span>
                </span>
            </p>
            
            <a href="/home/about/policies.shtml">Policies and Guidelines</a> | <a href="/home/about/contact.shtml">Contact</a>
        </div>
    </div>
    <script type="text/javascript" src="/portal/portal3rc.fcgi/rlib/js/InstrumentOmnitureBaseJS/InstrumentNCBIConfigJS/InstrumentNCBIBaseJS/InstrumentPageStarterJS.js?v=1"> </script>    
    <script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/hfjs2.js"> </script>
</div>
                        </div>
                    </div>
                    <!--/.page-->
                </div>
                <!--/.wrap-->
            </div><!-- /.twelve_col -->
        </div>
        <!-- /.grid -->

        <span class="PAFAppResources"></span>
        
        <!-- BESelector tab -->
        
        
        
        <noscript><img alt="statistics" src="/stat?jsdisabled=true&amp;ncbi_db=books&amp;ncbi_pdid=book-part&amp;ncbi_acc=NBK1280&amp;ncbi_domain=gene&amp;ncbi_report=record&amp;ncbi_type=fulltext&amp;ncbi_objectid=&amp;ncbi_pcid=/NBK1280/&amp;ncbi_pagename=Pachyonychia Congenita - GeneReviews® - NCBI Bookshelf&amp;ncbi_bookparttype=chapter&amp;ncbi_app=bookshelf" /></noscript>
        
        
        <!-- usually for JS scripts at page bottom -->
        <!--<component id="PageFixtures" label="styles"></component>-->
    

<!-- CE8903AFDFC94071_1856SID /projects/books/PBooks@5.22 portal102 v4.1.r585844 Mon, May 06 2019 02:53:16 -->

<script type="text/javascript" src="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/js/3879255/4121861/3501987/4008961/3893018/3821238/4062932/4123007/4087685/4076480/3921943/3400083/3426610.js" snapshot="books"></script></body>
</html>